<?xml version="1.0"?>
<rdf:RDF xmlns="http://purl.obolibrary.org/obo/cido-covid-19/external/PW_import2.owl#"
     xml:base="http://purl.obolibrary.org/obo/cido-covid-19/external/PW_import2.owl"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:obo="http://purl.obolibrary.org/obo/">
    <owl:Ontology rdf:about="http://purl.obolibrary.org/obo/cido-covid-19/external/PW_import2.owl"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasOBONamespace">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">has_obo_namespace</rdfs:label>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasExactSynonym">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">has_exact_synonym</rdfs:label>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#created_by"/>
    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#creation_date"/>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000412">
        <rdfs:label xml:lang="en">imported from</rdfs:label>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000115">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">definition</rdfs:label>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasAlternativeId">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">has_alternative_id</rdfs:label>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#hasRelatedSynonym">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">has_related_synonym</rdfs:label>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://www.w3.org/2000/01/rdf-schema#label"/>
    <owl:AnnotationProperty rdf:about="http://www.geneontology.org/formats/oboInOwl#id"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Datatypes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/PW_0000721 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000721">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nicotine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000923"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-01-18T03:34:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000721</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of nicotine, an alkaloid found in tobacco and other plants. It is an agonist of nicotinic acetylcholine receptors and exerts stimulatory roles. It is also responsible for tobacco dependence.  Prolonged exposure and high levels of nicotine can have toxic effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000722 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000722">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">warfarin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002325"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-01-18T03:34:31Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000722</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of warfarin. Warfarin is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000723 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000723">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">anti-diabetic drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000921"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-01-18T03:43:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000723</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of anti-diabetic drugs such as repaglinide, nateglinide and sulfonylurea - inhibitors of ATP-dependent potassium channel. By blocking the channel they stimulate insulin secretion to lower blood glucose level. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000724 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000724">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">statin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000920"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-01-19T10:48:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000724</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of statin. Statins are a class of drugs used to lower cholesterol. They act as inhibitors of HMG-CoA reductase, the enzyme that catalyzes an early rate-limiting step in cholesterol biosynthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000725 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000725">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">potassium channel inhibitors pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000723"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-01-20T12:12:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000725</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00453</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00454</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of anti-diabetic drugs-target interaction and of the biochemical or physiological responses to them. Repaglinide, nateglinide and sulfonylurea are used as inhibitors of ATP-dependent potassium channel. By blocking the channel they stimulate insulin secretion to lower blood glucose level. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000726 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000726">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">repaglinide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000723"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-01-20T12:14:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000726</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of repaglinide. The drug is used as an inhibitor of ATP-dependent potassium channel. By blocking the channel it stimulates insulin secretion to lower blood glucose level. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000727 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000727">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nateglinide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000723"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-01-20T12:15:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000727</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of nateglinide. The drug is used as an inhibitor of ATP-dependent potassium channel. By blocking the channel it stimulates insulin secretion to lower blood glucose level. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000728 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000728">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">statin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000724"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-01-20T12:21:51Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000728</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00082</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00089</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00092</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00099</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00111</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00119</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00131</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of statins-target interaction and of the biochemical or physiological responses to drug. Statins are a class of drugs used to lower cholesterol. They act as inhibitors of HMG-CoA reductase, the enzyme that catalyzes an early rate-limiting step in cholesterol biosynthesis. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000729 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000729">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">statin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000724"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-01-20T12:22:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000729</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of statin. Statins are a class of drugs used to lower cholesterol. They act as inhibitors of HMG-CoA reductase, the enzyme that catalyzes an early rate-limiting step in cholesterol biosynthesis. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000730 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000730">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">warfarin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000722"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-01-20T12:42:35Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000730</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of warfarin. Warfarin is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000731 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000731">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">warfarin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000722"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-01-20T12:42:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000731</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00268</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of warfarin-target interaction and of the biochemical or physiological responses to drug. Warfarin is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000754 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000754">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">drug pathway</rdfs:label>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-15T11:01:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000754</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and the pharmacodynamics pathway elicited by the administration of specific drugs. The systems involved in drug processing and responses are also those handling exogenous, xenobiotic compounds in the cellular detoxification pathway. The distinction between a random encounter with a foreign compound and the processing of a substance administered for treatment along with the importance of genetic variation for the individual responses to particular drugs warrant their separate consideration.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000755 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000755">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">benzodiazepine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002295"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-15T11:26:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000755</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of benzodiazepines, a class of drugs acting upon the central nervous system. The drugs are administered as sedatives and also as antiepileptics. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000756 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000756">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">benzodiazepine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000755"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-15T11:30:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000756</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of benzodiazepines. Benzodiazepine represent a class of drugs used as sedatives. They act as ligands for the GABA-A receptor to stimulate its inhibitory activity. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000757 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000757">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">benzodiazepine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000755"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-15T11:31:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000757</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of benzodiazepine-target interaction and of the biochemical or physiological responses to drug. Benzodiazepines are a class of drugs used as sedatives. They act as ligands for the GABA-A receptor to stimulate its inhibitory activity. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000758 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000758">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gemcitabine pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-17T08:04:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000758</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of gemcitabine, a cytidine analogue that is administered as a prodrug for the treatment of certain types of cancer. The diphosphate form is an inhibitor of ribonucleotide reductases, essential enzymes of deoxyribonucleotide synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000759 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000759">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gemcitabine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000758"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-17T08:18:10Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000759</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00603</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of gemcitabine. Gemcitabine is a cytidine analogue administered as a prodrug for the treatment of certain cancers. The diphosphate form is an inhibitor of ribonucleotide reductases, essential enzymes of deoxyribonucleotide synthesis. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000760 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000760">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gemcitabine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000758"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-17T08:27:03Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000760</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00446</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of gemcitabine-target interaction and of the biochemical or physiological responses to drug. Gemcitabine is a cytidine analogue that is administered as a prodrug for the treatment of certain types of cancer. The diphosphate form is an inhibitor of ribonucleotide reductases, essential enzymes of deoxyribonucleotide synthesis. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000761 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000761">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">celecoxib drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-17T08:51:56Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000761</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of celecoxib, a selective cyclooxygenase 2 inhibitor used for the treatment of osteoarthritis and rheumatoid arthritis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">celebrex pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000762 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000762">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">celecoxib pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000761"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-17T09:03:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000762</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00644</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of celecoxib - a selective inhibitor of cyclooxygenase 2 used for the treatment of osteoarthritis and rheumatoid arthritis. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">celebrex pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000763 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000763">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">celecoxib pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000761"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-17T09:14:56Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000763</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00096</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of celecoxib-target interaction and of the biochemical or physiological responses to drug. Celecoxib is a selective inhibitor of cyclooxygenase 2 used for the treatment of osteoarthritis and rheumatoid arthritis. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">celebrex pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000764 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000764">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ifosfamide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-22T01:04:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000764</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of ifosfamide, am antitumor agent used in the treatment of certain cancers. It is administered as a prodrug that has to be converted to the active form. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000765 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000765">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ifosfamide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000764"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-22T01:13:38Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000765</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00605</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of ifosfamide, a prodrug used against solid tumors. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000766 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000766">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ifosfamide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000764"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-22T01:21:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000766</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00448</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ifosfamide-target interaction and of the biochemical or physiological responses to drug. Ifosfamide is administered as a prodrug and is widely used as an alkylating agent for the treatment of certain cancers. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000767 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000767">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">omeprazole drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000918"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-22T01:39:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000767</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of omeprazole, a proton pump inhibitor. Omeprazole is the representative compound of a class of such inhibitors that are administered for the treatment of acid-related disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000768 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000768">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">omeprazole pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000767"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-22T01:44:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000768</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00613</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of omeprazole, a representative compound of a class of proton pump inhibitors. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000769 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000769">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">omeprazole pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000767"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-03-22T01:50:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000769</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00226</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of omeprazole-target interaction and of the biochemical or physiological responses to drug. Omeprazole is a representative compound of a class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000799 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000799">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">adrenergic beta receptor drug pathway - beta-agonist and beta-blocker</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000920"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000924"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-06-30T10:47:27Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000799</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of adrenergic beta receptors drugs - beta-agonists and blockers. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta-agonists are used to stimulate while beta-blocker antagonists are used to inhibit these responses, as necessary. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000800 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000800">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">adrenergic beta receptor agonist and beta-blocker pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000799"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-07-01T08:56:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000800</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of beta adrenergic receptor drugs. The beta-agonists are used to stimulate while the beta-blockers are used to inhibit the action of adrenergic beta receptors, as necessary. Adrenergic beta receptors are G-protein coupled receptors that in response to epinephrine or norepinephrine elicit various sympathetic responses important for proper cardiac function and in the case of beta2 receptor, smooth muscle relaxation and bronchodilation. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000801 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000801">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">adrenergic beta receptor agonist and beta-blocker pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000799"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010-07-01T09:12:37Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000801</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00296</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00297</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of beta adrenergic drug-target interactions and of the biochemical or physiological responses to drug. The beta-agonists are used to stimulate while the beta-blockers are used to inhibit the action of adrenergic beta receptors, as necessary. Adrenergic beta receptors are G-protein coupled receptors that in response to epinephrine or norepinephrine elicit various sympathetic responses important for proper cardiac function and in the case of beta2 receptor, smooth muscle relaxation and bronchodilation. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000835 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000835">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">anti-estrogen drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011-01-06T02:11:32Z</oboInOwl:creation_date>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Breast cancer is a major cause of death among Western women and many breast tumors are estrogen-dependent. Pharmacologically two major therapies have been developed: one targets the estrogen receptors via antagonists and selective modulators (SERM) and the second targets estrogen synthesis via aromatase inhibitors.</obo:IAO_0000115>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000835</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000836 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000836">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">aromatase inhibitor pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000835"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011-01-07T05:07:46Z</oboInOwl:creation_date>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Aromatase inhibitors block the last step of estrogen biosynthesis. They can be classified into first-, second- and third-generation drugs. Depending on whether they inactivate the aromatase complex irreversibly or reversibly, they can be further subdivided into type I and II, respectively. Currently, third generation drugs are being used.</obo:IAO_0000115>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000836</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000837 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000837">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tamoxifen drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000835"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011-01-17T01:05:40Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000837</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of tamoxifen - one of the most widely used anti-estrogen drug that targets the estrogen receptor. The drug is a modulator than acts as an antagonist in breast cancer cells but can be an agonist in bone and the cardiovascular system. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000838 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000838">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tamoxifen pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000837"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011-01-17T01:06:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000838</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00606</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of tamoxifen - a SERM anti-estrogen drug. Genetic variations can result in changes in the availability of the drug. For instance, variation in CYP2D6, an important enzyme for the production of a primary drug metabolite, impacts on the available concentration of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000839 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000839">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tamoxifen pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000837"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011-01-17T01:06:59Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000839</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00471</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of tamoxifen-target interaction and of the biochemical or physiological responses to drug. In breast cancer cells, tamoxifen binding antagonizes estrogen binding and the subsequent conformational changes necessary for co-activators recruitment. It may also prompt the recruitment of co-repressor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000869 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000869">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gefitinib drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011-06-09T05:30:25Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000869</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of gefitinib. Gefitinib is the first selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000870 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000870">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gefitinib pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000869"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011-06-09T05:30:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000870</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of gefitinib. Gefitinib is the first selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000871 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000871">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gefitinib pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000869"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011-06-09T05:31:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000871</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00473</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of gefitinib-target interactions and of the biochemical or physiological responses to drug. Gefitinib is the first selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000872 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000872">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">erlotinib drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011-06-14T03:33:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000872</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of erlotinib. Erlotinib is the second (after gefitinib) selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000873 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000873">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">erlotinib pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000872"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011-06-14T03:33:51Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000873</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of erlotinib. Erlotinib is the second (after gefitinib) selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000874 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000874">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">erlotinib pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000872"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011-06-14T03:34:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000874</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00472</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of erlotinib-target interaction and of the biochemical or physiological responses to drug. Erlotinib is the second (after gefitinib) selective inhibitor of EGFR whose mutations within the tyrosine kinase domain have been associated with hyperactive epidermal growth factor signaling in non-small cell lung cancers. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000918 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000918">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">proton pump inhibitor drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000921"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-03-28T02:13:39Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000918</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of proton pump inhibitor (PPI), a class of compounds that block the acid secretion from parietal cells in the stomach. A representative PPI compound is omeprazole. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000919 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000919">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">antineoplastic and immunomodulatory drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-03-28T02:35:45Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000919</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used as antineoplastic or as immunomodulatory agents. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000920 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000920">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cardiovascular system drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-03-28T02:45:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000920</oboInOwl:id>
        <oboInOwl:hasAlternativeId rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002488</oboInOwl:hasAlternativeId>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used for the treatment of various cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasExactSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dermatological drug pathway</oboInOwl:hasExactSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000921 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000921">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">alimentary tract and metabolism drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-03-28T02:49:20Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000921</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used for the treatment of alimentary tract and metabolism-related conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000922 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000922">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">blood and blood forming organs drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-03-28T02:55:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000922</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions associated with blood and blood forming organs. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000923 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000923">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nervous system drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-03-28T02:58:10Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000923</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions associated with the nervous system. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000924 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000924">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">respiratory system drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-04-05T03:45:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000924</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions associated with the respiratory system. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000927 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000927">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">anti-tumor necrosis factor drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002369"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-04-26T02:36:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000927</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tumor necrosis factor (TNF) inhibitors are used in the treatment of rheumatoid arthritis. The inhibitors are recombinant proteins that bind the soluble and membrane-associated TNF and inhibit the effects of this pro-inflammatory cytokine.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">anti-TNF drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000928 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000928">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tocilizumab drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002369"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-04-26T03:00:42Z</oboInOwl:creation_date>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Actemra drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000928</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tocilizumab is a humanized anti-interleukin 6 (Il-6) receptor antibody used in the treatment of patients with rheumatoid arthritis, Castleman&#39;s disease or juvenile idiopathic arthritis. Tocilizumab binds to the soluble and membrane associated interleukin-6 receptor and competitively blocks binding of interleukin-6 to its receptor(s) and inhibits the effects of this potent cytokine.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000929 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000929">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">anakinra drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002369"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-04-26T03:26:25Z</oboInOwl:creation_date>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Anakinra is a recombinant, non-glycosylated version of the human interleukin-1 (Il-1) receptor antagonist used for the treatment of inflammation associated with rheumatoid arthritis. Like the natural antagonist, anakinra competitively inhibits binding of interleukin-1 to its receptor and the subsequent effects of this potent pro-inflammatory cytokine.</obo:IAO_0000115>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000929</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">kineret drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000930 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000930">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">methotrexate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002369"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-04-27T01:27:25Z</oboInOwl:creation_date>
        <oboInOwl:hasExactSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">MTX drug pathway</oboInOwl:hasExactSynonym>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000930</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of methotrexate (MTX), a polyglutamatable antifolate used in the treatment of cancers and autoimmune diseases. The impact of MTX on cancer and rheumatoid arthritis is thought to arise through distinct mechanisms and pharmacodynamics pathways. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000931 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000931">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">methotrexate pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000930"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-04-27T01:46:47Z</oboInOwl:creation_date>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">MTX pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000931</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of methotrexate (MTX), a folate analogue used in the treatment of cancers and autoimmune diseases. Genetic variations can result in changes in the availability of the drug and It is believed that variability in MTX pharmacokinetics is linked to genetic variations in transporter proteins.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000932 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000932">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">methotrexate pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000930"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-04-27T02:16:39Z</oboInOwl:creation_date>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">MTX pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000932</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00432</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of methotrexate-target interaction and of the biochemical or physiological responses to drug. The impact of MTX on cancer and rheumatoid arthritis is thought to arise through distinct mechanisms and pharmacodynamics pathways. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0000996 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0000996">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">anti-infective drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-05-25T11:37:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0000996</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used as anti-infective agents. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001095 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001095">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">zidovudine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-08-03T11:18:59Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001095</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of zidovudine, an anti-viral drug used for the treatment of HIV infection. It belongs to the family of nucleoside analog reverse transcriptase inhibitors. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ZDV drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001096 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001096">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">zidovudine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001095"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-08-03T11:23:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001096</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of zidovudine, a drug used for the treatment of HIV. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001097 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001097">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">zidovudine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001095"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-08-03T11:25:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001097</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of zidovudine-target interaction and of the biochemical or physiological responses to drug. Zidovudine is a drug used for the treatment of HIV infection. Zidovudine, in its active triphosphate form, inhibits HIV-1 reverse transcriptase activity. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001098 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001098">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tramadol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-08-03T11:37:59Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001098</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of tramadol, an analgesic used for the treatment of moderate to moderately severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001099 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001099">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tramadol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001098"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-08-03T11:41:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001099</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00637</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of tramadol, an analgesic used in the treatment of pain. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001100 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001100">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tramadol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001098"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-08-03T11:41:20Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001100</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00671</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of tramadol-target interaction and of the biochemical or physiological responses to drug. Tramadol is an analgesic used for the treatment of pain. The drug and its o-desmethyl metabolite are weak, but selective opiate receptor 3 (OP3) agonists. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001107 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001107">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sorafenib drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-04T15:24:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001107</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of sorafenib, a multikinase inhibitor used in the treatment of cancer, in particular for advanced renal cell carcinoma.  The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001108 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001108">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sorafenib pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001107"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-04T15:30:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001108</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00648</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of sorafenib. The drug was the first oral multikinase inhibitor approved for the treatment of renal cell carcinoma. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001109 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001109">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sorafenib pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001107"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-04T15:31:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001109</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of sorafenib-target interaction and of the biochemical or physiological responses to drug. Sorafenib is the first multikinase inhibitor approved for the treatment of renal cell carcinoma.  The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001110 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001110">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sunitinib drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-04T15:54:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001110</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of sunitinib, a multikinase inhibitor used in the treatment of cancer, in particular for advanced renal cell carcinoma. The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001111 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001111">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tocilizumab pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000928"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-04T15:57:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001111</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001112 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001112">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tocilizumab pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000928"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-04T15:57:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001112</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001113 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001113">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sunitinib pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001110"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-04T15:58:20Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001113</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of sunitinib. The drug is a multikinase inhibitor approved for the treatment of renal cell carcinoma. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001114 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001114">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sunitinib pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001110"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-04T15:58:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001114</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of sunitinib-target interaction and of the biochemical or physiological responses to drug. Sunitinib is a multikinase inhibitor approved for the treatment of renal cell carcinoma. The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001120 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001120">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bevacizumab drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002370"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-15T08:49:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001120</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of bevacizumab, a humanized monoclonal antibody that inhibits VEGF activity. It is used for the treatment of several types of advanced cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001121 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001121">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bevacizumab pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001120"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-15T08:56:41Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001121</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of bevacizumab, a VEGF inhibitor used in the treatment of several types of  tumors. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001122 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001122">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bevacizumab pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001120"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-15T08:57:45Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001122</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00420</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of bevacizumab-target interaction and of the biochemical or physiological responses to drug. The drug is an inhibitor of VEGF and is used in the treatment of several types of cancers such as for instance renal cell carcinoma. VEGF is a target of hypoxia inducible factor pathway, which is constitutively active in the condition.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001123 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001123">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">axitinib drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-19T11:46:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001123</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of axitinib, a receptor tyrosine kinase inhibitor used in the treatment of renal cell carcinoma as well as other tumors. Angiogenic factors such as vascular endothelial or platelet derived growth factors are direct and indirect targets of hypoxia inducible factor pathway, constitutively active in renal cell carcinoma. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001124 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001124">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">axitinib pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001123"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-19T11:49:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001124</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of axitinib, a receptor tyrosine kinase inhibitor used in the treatment of renal cell carcinoma and other tumors. Axitinib is a selective second generation inhibitor of vascular endothelial growth factor receptors 1, 2 and 3. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001125 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001125">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">axitinib pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001123"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-19T11:50:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001125</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of axitinib-target interaction and of the biochemical or physiological responses to drug. Axitinib is a receptor tyrosine kinase inhibitor used in the treatment of renal cell carcinoma as well as other tumors. Axitinib is a selective second generation inhibitor of vascular endothelial growth factor receptors 1, 2 and 3. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001126 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001126">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">everolimus drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002369"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-19T13:54:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001126</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of everolimus, an inhibitor of mTOR pathway used in the treatment of several types of tumors, including renal cell carcinoma. Hypoxia inducible factor (HIF) pathway is constitutively active in the disease; mTOR regulates the translation of HIF-alpha gene. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001127 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001127">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">everolimus pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001126"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-19T15:41:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001127</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of everolimus, an inhibitor of mTOR pathway used in the treatment of renal cell carcinoma and other tumors. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001128 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001128">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">everolimus pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001126"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-19T15:45:06Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001128</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of everolimus-target interactions and of the biochemical or physiological responses to drug. The drug is an inhibitor of mTOR pathway and is used in the treatment of renal cell carcinoma and other types of tumors. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001129 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001129">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">temsirolimus drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-19T16:04:14Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001129</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of temsirolimus, an inhibitor of mTOR pathway used in the treatment of renal cell carcinoma and other types of tumors. Hypoxia inducible factor (HIF) pathway is constitutively active in renal cell carcinoma; HIF-alpha translation is under the control of mTOR pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001130 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001130">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">temsirolimus pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001129"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-19T16:12:25Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001130</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of temsirolimus, an inhibitor of mTOR pathway used in the treatment of renal cell carcinoma and other tumors. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001131 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001131">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">temsirolimus pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001129"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-19T16:12:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001131</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of temsirolimus-target interaction and of the biochemical or physiological responses to drug. The drug is an inhibitor of mTOR pathway and is used in the treatment of renal cell carcinoma and other types of tumors. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001132 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001132">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pazopanib drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-19T16:13:35Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001132</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of pazopanib, a receptor tyrosine kinase inhibitor used in the treatment of renal cell carcinoma as well as other tumors. Angiogenic factors such as vascular endothelial or platelet derived growth factors are direct and indirect targets of hypoxia inducible factor pathway, constitutively active in renal cell carcinoma. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001133 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001133">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pazopanib pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001132"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-19T16:13:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001133</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">he pathway of processing - absorption, distribution, metabolism or elimination - of pazopanib. The drug is a multikinase inhibitor approved for the treatment of renal cell carcinoma. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001134 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001134">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pazopanib pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001132"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012-10-19T16:14:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001134</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of pazopanib-target interaction and of the biochemical or physiological responses to drug. Pazopanib is a selective multikinase inhibitor approved for the treatment or renal cell carcinoma. The drug binds to the intracytoplasmic domain of tyrosine kinase receptors blocking the downstream signaling cascade. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001170 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001170">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">musculo-skeletal system drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-01-21T15:17:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001170</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions associated with the musculo-skeletal system. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001202 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001202">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">genito-urinary system and sex hormones drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-03-26T11:29:09Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001202</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used for the treatment of genito-urinary system conditions or as sex hormones derivatives and analogs. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001203 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001203">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">systemic hormones drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-03-26T12:01:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001203</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of hormonal preparations that may contain natural hormones or are synthetic hormonal analogs and their derivatives. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001204 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001204">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">thyromimetics drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001203"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-03-26T12:24:40Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001204</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of thyroid hormone analogs, many of which have tissue specific thyroid hormone action.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001205 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001205">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sobetirome drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001204"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-03-26T12:31:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001205</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sobetirome, also known as GC-1, is a one of the best characterized thyromimetics with high affinity for the beta thyroid receptor. It has been shown to reduce LDL cholesterol in animal model studies.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001206 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001206">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">eprotirome drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001204"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-03-26T12:36:58Z</oboInOwl:creation_date>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eprotirome is a thyromimetics that in addition for being selective for the beta tyrosine receptor is also highly liver-selective with minimal uptake in non-hepatic tissues. In overweight and hypercholesterolemic patients, its administration lead to lowering of total and LDL-cholesterol while stimulating bile acid biosynthesis.</obo:IAO_0000115>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001206</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001210 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001210">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">plevitrexed drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-04-05T09:15:35Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001210</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of plevitrexed, a non-polyglutamatable antifolate quinazoline derivative and thymidylate synthase inhibitor used in the treatment of cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001211 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001211">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">plevitrexed pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001210"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-04-05T09:18:45Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001211</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of plevitrexed, an antifolate used in the treatment of cancer. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001212 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001212">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">plevitrexed pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001210"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-04-05T09:19:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001212</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of plevitrexed-target interactions and of the biochemical or physiological responses to drug. The drug is an antifolate that targets thymidylate synthase and is used in the treatment of several cancers. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001213 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001213">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pemetrexed drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-04-05T09:21:07Z</oboInOwl:creation_date>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Alimta drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001213</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of permetrexed, an antifolate originally designed as a thymidylate synthase inhibitor but which also has inhibitory effects on other enzymes involved in the folate cycle and/or folate mediated one-carbon transfer reactions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001214 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001214">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pemetrexed pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001213"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-04-05T09:27:10Z</oboInOwl:creation_date>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Alimta pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001214</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of pemetrexed-target interactions and of the biochemical or physiological responses to drug. The drug is an antifolate that targets thymidylate synthase and other enzymes of the folate cycle and folate mediated one-carbon transfer reactions and is used in the treatment of several cancers. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001215 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001215">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pemetrexed pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001213"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-04-05T09:27:34Z</oboInOwl:creation_date>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Alimta pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001215</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of pemetrexed, an antifolate used in the treatment of cancer. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001216 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001216">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pralatrexate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-04-05T09:34:53Z</oboInOwl:creation_date>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Folotyn drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001216</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of pralatrexate, a polyglutamatable antifolate used as an inhibitor of dihydrofolate reductase (DHFR) enzyme of folate cycle. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001217 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001217">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pralatrexate pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001216"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-04-05T09:38:36Z</oboInOwl:creation_date>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Folotyn pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001217</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of pralatrexed, an antifolate used in the treatment of cancer. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001218 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001218">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pralatrexate pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001216"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-04-05T09:39:53Z</oboInOwl:creation_date>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Folotyn pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001218</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of pralatrexed-target interactions and of the biochemical or physiological responses to drug. The drug is an antifolate that targets dihydrofolate reductase (DHFR) and is used in the treatment of some cancers. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001224 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001224">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">irinotecan drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-05-03T10:54:39Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001224</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of irinotecan an inhibitor of DNA topoisomerase I used in the treatment of several types of cancer. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001225 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001225">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">irinotecan pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001224"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-05-03T10:58:59Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001225</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00600</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of irinotecan, a drug used in the treatment of several types of cancer. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001226 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001226">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">irinotecan pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001224"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-05-03T10:59:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001226</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00433</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of irinotecan-target interactions and of the biochemical or physiological responses to drug. Irinotecan is a DNA topoisomerase I inhibitor used in the treatment of several types of cancer. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001228 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001228">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ACE inhibitor drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001789"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-05-03T11:54:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001228</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of drugs that target the angiotensin converting enzyme ACE. In the renin-angiotensin cascade, several bioactive peptides are derived from the precursor angiotensinogen. ACE converts angiotensin I to the potent angiotensin II. The various ACE inhibitors are grouped based on their molecular structure, the dicarboxylate-containing agents represent the largest group. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001230 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001230">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ACE inhibitor pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-05-07T16:04:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001230</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of ACE inhibitors. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001231 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001231">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ACE inhibitor pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-05-07T16:05:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001231</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ACE inhibitor-target interaction and of the biochemical or physiological responses to drug. The drugs are used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001244 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001244">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">codeine and morphine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-05-08T10:38:09Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001244</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of codeine and morphine, a class of drugs in the opiate family used as pain relievers. Both are naturally found in the poppy plant with codeine derived from the more abundant morphine, as methylated morphine. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001245 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001245">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">codeine and morphine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001244"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-05-08T10:42:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001245</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00621</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00622</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of codeine and morphine, a class of drug opiates used as pain relievers. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001246 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001246">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">codeine and morphine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001244"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-05-08T10:42:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001246</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00405</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00406</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of codeine/morphine-target interaction and of the biochemical or physiological responses to drug. The drugs are potential ligands for the mu-opioid receptor, a class of opioid receptor. Opioid receptors are G-protein coupled receptors (GPCR) activated by endogenous and also exogenous opioids. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001247 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001247">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nifedipine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001894"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-05-08T11:07:26Z</oboInOwl:creation_date>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Adalat CC drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001247</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Procardia drug pathway</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of nifedipine, a calcium channel blocker used primarily in the treatment of hypertension and angina. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001248 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001248">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nifedipine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001247"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-05-08T11:17:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001248</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of nifedipine. The drug is a calcium channel blocker used in the treatment of hypertension and angina.  Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001249 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001249">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nifedipine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001247"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-05-08T11:18:25Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001249</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00379</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of nifedipine-target interaction and of the biochemical or physiological responses to drug. The drug is a calcium channel blocker, particularly the L-type channel.  Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001418 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001418">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">abciximab drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002150"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T11:09:26Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001418</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of abciximab, an integrin receptor antagonist used as a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001419 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001419">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">abciximab pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001418"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T11:13:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001419</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of abciximab, a platelet aggregation inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001420 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001420">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">abciximab pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001418"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T11:15:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001420</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00265</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of abciximab-target interaction and of the biochemical or physiological responses to drug. Abciximab is an antagonist of the integrin alpha2b/beta3 complex found on platelets. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001421 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001421">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">kanamycin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T11:51:37Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001421</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of kanamycin, an aminoglycoside antibiotic that inhibits bacterial protein synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001422 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001422">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">kanamycin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001421"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T12:02:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001422</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of kanamycin - an antibiotic that interferes with bacterial protein synthesis. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001423 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001423">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">kanamycin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001421"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T12:04:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001423</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00255</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of kanamycin-target interaction and of the biochemical or physiological responses to drug. Kanamycin interferes with bacterial protein synthesis and is used in the treatment of several infections caused by both Gram-negative and Gram-positive bacteria. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001424 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001424">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">neviparine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T12:10:20Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001424</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of neviparine, a non-nucleoside reverse transcriptase inhibitor used in the treatment of HIV type 1. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001425 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001425">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">neviparine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001424"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T12:30:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001425</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00642</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of neviparine, a reverse transcriptase inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001426 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001426">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">neviparine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001424"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T12:31:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001426</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00743</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of neviaparine-target interaction and of the biochemical or physiological responses to drug. Neviparine is a non-nucleoside reverse transcriptase inhibitor used in combination with other antiretroviral drugs  for the treatment of HIV type. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001427 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001427">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amikacin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T12:53:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001427</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of amikacin, an aminoglycoside antibiotic that inhibits bacterial protein synthesis. It is used for the treatment of infections induced by Gram-negative bacteria. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001428 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001428">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amikacin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001427"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T12:55:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001428</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of amikacin, an antibiotic used for the treatment of infections induced by Gram-negative bacteria. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001429 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001429">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amikacin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001427"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T12:57:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001429</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00253</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of amikacin-target interaction and of the biochemical or physiological responses to drug. Amikacin inhibits bacterial protein synthesis and is used for the treatment of infections induced by Gram-negative bacteria. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001430 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001430">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lamivudine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T13:09:51Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001430</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of lamivudine, a reverse transcriptase enzyme inhibitor used for the treatment of HIV type 1 and 2 and Hepatitis B virus. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001431 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001431">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lamivudine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001430"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T13:12:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001431</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00649</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of lamivudine, a reverse transcriptase inhibitor used for the treatment of several virally induced diseases. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001432 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001432">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lamivudine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001430"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T13:17:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001432</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00742</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of lamivudine-target interaction and of the biochemical or physiological responses to drug. Lamivudine is a a reverse transcriptase enzyme inhibitor used for the treatment of HIV typ1 and 2 and Hepatitis B. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001433 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001433">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gentamicin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-07-01T13:22:06Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001433</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of gentamicin, an antibiotic that inhibits bacterial protein synthesis. The drug can cause inner ear and kidney problems. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001443 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001443">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ezetimibe drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000920"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-08-26T09:32:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001443</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of ezetimibe - a drug used to lower the plasma cholesterol level. Ezetimibe is a selective cholesterol absorption inhibitor used both as monotherapy and in combination with statins. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zetia drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001444 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001444">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ezetimibe pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-08-26T09:33:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001444</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of ezetimibe, a selective inhibitor of cholesterol absorption. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zetia pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001445 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001445">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ezetimibe pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-08-26T09:34:53Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001445</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ezetimibe-target interaction and of the biochemical or physiological responses to drug. Ezetimibe is a selective inhibitor of cholesterol absorption used both as monotherapy and in combination with statins. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zetia pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001446 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001446">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lomitapide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000920"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-08-26T09:40:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001446</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of lomitapide, a drug used to lower cholesterol levels. Lomitapide is an inhibitor of microsomal triglyceride transfer protein used both as monotherapy and in combination with statins. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001447 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001447">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lomitapide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001446"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-08-26T09:41:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001447</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of lomitapide, an inhibitor of microsomal triglyceride transfer protein. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001448 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001448">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lomitapide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001446"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-08-26T09:41:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001448</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of lomitapide-target interaction and of the biochemical or physiological responses to drug. The drug is an inhibitor of microsomal triglyceride transport protein and used to lower cholesterol levels. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001449 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001449">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nicotine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000721"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-08-28T13:57:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001449</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00628</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of nicotine, an agonist of nicotinic acetylcholine receptors. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001450 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001450">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nicotine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000721"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-08-28T13:58:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001450</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00431</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of nicotine-target interaction and of the biochemical or physiological responses to drug. Nicotine is an agonist of the nicotinic acetylcholine receptors and exerts stimulatory roles. It is also responsible for tobacco dependence.  Prolonged exposure and high levels of nicotine can have toxic effects. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001451 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001451">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">valproic acid drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002295"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-08-28T14:01:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001451</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of valproic acid, a branched short-chain fatty acid derived from valeric acid used as a mood-stabilizing drug and in the treatment of epilepsy. More recently it has also been found to inhibit the proliferation of cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">valproate drug pathway</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001452 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001452">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">valproic acid pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001451"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-08-28T14:04:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001452</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00635</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of valproic acid, a drug used as a mood-stabilizing and for the treatment of epilepsy. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">valproate pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001453 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001453">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">valproic acid pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001451"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-08-28T14:05:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001453</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of valproic acid-target interaction and of the biochemical or physiological responses to drug. Valproic acid is used as a mood-stabilizing drug and in the treatment of epilepsy. More recently it has also been found to inhibit the proliferation of cancers. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">valproate pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001455 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001455">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">doxorubicin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-08-29T15:06:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001455</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of doxorubicin, a streptomyces metabolite used as a chemotherapeutic agent used in the treatment of cancers. However, its use is limited by the serious cardiotoxic side effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001456 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001456">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nystatin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001202"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-09-05T17:25:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001456</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of nystatin - a polyene antifungal drug used to treat yeast infections. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001457 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001457">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nystatin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001456"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-09-05T17:29:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001457</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination -of nystatin. Nystatin is an antifungal that binds to ergosterol - a component of the fungal cell membrane, and also with cholesterol. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001458 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001458">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nystatin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001456"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-09-05T17:29:50Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001458</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of nystatin-target interactions and of the biochemical or physiological responses to drug. Nystatin interacts with both the fungal ergosterol and the host cholesterol but its afinity for ergosterol is higher. The interaction with cholesterol impacts on the uptake and activity of the anti-angiogenic endostatin.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001459 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001459">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amphotericin B drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001202"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-09-05T17:30:56Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001459</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001460 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001460">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amphotericin B pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001459"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-09-05T17:31:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001460</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001461 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001461">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amphotericin B pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001459"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-09-05T17:31:50Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001461</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001462 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001462">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">losartan drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001789"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-09-20T15:43:56Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001462</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of losartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension and heart failure. Losartan is one of several angiotensin II receptor type 1 antagonists and the first used on the market. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001463 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001463">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">losartan pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001462"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-09-20T15:47:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001463</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of losartan. The drug is an angiotensin II receptor type 1 antagonist used in the treatment of hypertension and heart failure. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001464 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001464">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">losartan pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001462"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-09-20T15:48:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001464</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00162</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of losartan-target interaction and of the biochemical or physiological responses to drug. Losartan is an angiotensin II receptor type 1 antagonist used in the treatment of hypertension and heart failure. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001465 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001465">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">clopidogrel drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002150"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-10-25T12:06:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001465</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of clopidogrel, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001466 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001466">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">clopidogrel pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001465"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-10-25T12:07:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001466</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00610</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of clopidogrel. The drug is an inhibitor of ADP-dependent platelet activation and aggregation. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001467 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001467">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">clopidogrel pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001465"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-10-25T12:08:38Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001467</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00260</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of clopidogrel-target interaction and of the biochemical or physiological responses to drug. The drug is an inhibitor of purinergic receptor P2RY12 a G-protein coupled receptor and chemoreceptor for adenosine diphosphate (ADP) receptor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001468 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001468">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ibuprofen drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000920"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001202"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001546"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-10-25T12:10:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001468</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of ibuprofen, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and is used in the treatment of inflammation and pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001469 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001469">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ibuprofen pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001468"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-10-25T12:11:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001469</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00590</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of ibuprofen. The drug is used in the treatment of pain and inflammation. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001470 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001470">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ibuprofen pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001468"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-10-25T12:12:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001470</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00086</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ibuprofen-target interaction and of the biochemical or physiological responses to drug. Ibuprofen is an inhibitor of cyclooxygenase enzymes used in the treatment of pain and inflammation. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001485 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001485">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">losartan-gene, gene-chemical, gene-gene interaction pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001462"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-11-22T14:43:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001485</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The expanded network of losartan-interacting genes.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001488 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001488">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">metformin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000723"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-12-17T09:44:50Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001488</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of metformin, an antihyperglycemic drug used in the treatment of type 2 diabetes mellitus. Metformin has also been shown to have a  tumor suppressor function. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001489 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001489">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">metformin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001488"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-12-17T09:49:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001489</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of metformin, an anti-diabetic drug used in the treatment of type 2 diabetes mellitus. Metformin is widely distributed in various tissues. Meformin is excreted unchanged and several transporters are involved in its tissue uptake and elimination. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001490 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001490">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">metformin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001488"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013-12-17T09:49:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001490</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of metformin-target interaction and of the biochemical or physiological responses to drug. Metformin lowers blood glucose levels by promoting the activation of AMPK signaling via molecular mechanisms that are not well understood. Mitochondria is the primary target of metformin which specifically inhibits complex I of the respiratory chain. The resulting change in AMP:ATP ratio can contribute to AMPK activation. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001491 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001491">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">metformin-gene, gene-chemical, gene-gene interaction pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001488"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014-01-07T14:13:24Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001491</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The expanded network of metformin-interacting genes.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001507 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001507">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">platinum (Pt) containing drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014-02-26T10:07:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001507</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics/pharmacodynamics of platinum (Pt) containing drugs, widely used in the treatment of cancer. These drugs introduce intra- and inter-strand DNA breaks. The DNA lesion and responses it triggers is toxic to tumor cells. However, it can also exert toxic side effects. Three Pt-containing drugs are being used and they vary in their efficacy and toxicity. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001508 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001508">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cisplatin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001507"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014-02-26T10:16:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001508</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics/pharmacodynamics of cisplatin, a platinum (Pt) containing drug widely used in the treatment of solid tumors. Cisplatin is the most potent of such drugs, it si also the one with the strongest toxic side effects. Nephorotoxicity and ototoxicity are among the primary toxic side effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001512 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001512">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">oxaliplatin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001507"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014-02-26T11:28:09Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001512</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics/pharmacodynamics of oxaliplatin, a platinum (Pt) containing drug widely used in the treatment of solid tumors. While less potent than cisplatin - the most potent of the platinum containing drugs, oxaliplatin is also less toxic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001513 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001513">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">carboplatin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001507"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014-02-26T12:00:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001513</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics/pharmacodynamics of carboplatin, a platinum (Pt) containing drug used in the treatment of solid tumors. It is not as effective as cisplatin and while exerting less severe side affects, it can lead to myelosuppression and thrombocytopenia. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001524 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001524">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">paracetamol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001546"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014-04-17T11:01:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001524</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00710</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics/pharmacodynamics of paracetamol, a widely used analgesic, known as acetaminophen (APAP). The analgesic effect is believed to be due to the inhibition of prostaglandins biosynthesis. Paracetamol overdose is associated with hepatic toxicity and a leading cause of liver failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasExactSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">acetaminophen drug pathway</oboInOwl:hasExactSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001525 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001525">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">paracetamol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001524"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014-04-17T11:18:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001525</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00640</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of paracetamol, a widely used analgesic known as acetaminophen. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasExactSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">acetaminophen pharmacokinetics pathway</oboInOwl:hasExactSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001546 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001546">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">analgesic and/or antipyretic drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000923"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014-05-14T15:55:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001546</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used to alleviate pain and/or reduce fever. Examples include the nonsteroidal anti-inflammatory drugs such as aspirin or ibuprofen and the widely used paracetamol, known as acetaminophen, among others.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001565 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001565">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">doxorubicin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001455"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014-11-07T13:23:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001565</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00650</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of doxorubicin. Doxorubicin is used as a chemotherapeutic agent for the treatment of various cancers. Its use is limited by the serious cardiotoxic side effects it exerts. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001566 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001566">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">doxorubicin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001455"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014-11-07T13:28:02Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001566</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of doxorubicin-target interaction and of the biochemical or physiological responses to drug. Doxorubicin is used as a chemotherapeutic agent for the treatment of many cancers. Its use is restricted by the serious cardiotoxic effects it exerts. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001595 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001595">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">abacavir drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-10T13:29:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001595</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of abacavir, an anti-viral drug used for the treatment of HIV infection. It belongs to the family of nucleoside analog reverse transcriptase inhibitors. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001596 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001596">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">abacavir pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001595"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-10T13:39:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001596</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of abacavir, a drug used for the treatment of HIV. Genetic variations can result in changes in the availability of the drug. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001597 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001597">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">abacavir pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001595"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-10T13:39:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001597</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00737</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of abacavir-target interaction and of the biochemical or physiological responses to them. Abacavir is a drug used for the treatment of HIV infection. Abacavir inhibits HIV-1 reverse transcriptase activity by competing with the natural substrate dGTP and by its incorporation into viral DNA whose growth is then terminated. Genetic variations can cause differences in the response of the organism to the drug. A small percentage of individuals receiving the drug develop immune-mediated hypersensitivity reactions (HSR), those carrying a variant in the human leukocyte antigen B (HLA-B) gene.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001598 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001598">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">acenocoumarol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002325"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-10T16:06:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001598</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of acenocoumarol. Acenocoumarol  is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001599 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001599">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">acenocoumarol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001598"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-10T16:08:41Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001599</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of acenocoumarol. Acenocoumarol is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001600 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001600">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">acenocoumarol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001598"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-10T16:09:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001600</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00269</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of acenocoumarol-target interaction and of the biochemical or physiological responses to drug. Acenocoumarol is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001613 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001613">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">acetylsalicylic acid drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000921"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001546"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002150"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-12T13:47:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001613</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of acetylasalicylic acid, known as aspirin. It is a non-steroidal anti-inflammatory drug (NSAID) used as analgesic, antipyretic and antitrombic agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">aspirin drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001614 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001614">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">acetylsalicylic acid pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001613"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-12T14:15:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001614</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of acetylsalicylic acid, known as aspirin. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">aspirin pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001615 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001615">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">acetylsalicylic acid pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001613"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-12T14:15:37Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001615</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00083</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The actual targets of acetylsalicylic acid known as aspirin were discovered after the drug was marketed. It was believed that it acts upon the central nervous system, but its true mode of action is to  irreversibly inhibit  cuclooxygenase enzyme COX-1 and to a lesser extent COX-2, thus suppressing the downstream production of prostaglandins and thromboxanes. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">aspirin pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001616 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001616">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">adefovir drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-12T14:35:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001616</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of adefovir, an anti-viral drug used for the treatment of hepatitis B. It is administered as adefovir dipivoxil prodrug. Once metabolized, it acts as a nucleotide analog reverse transcriptase inhibitor.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001617 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001617">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">adefovir pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001616"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-12T14:44:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001617</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00629</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of adefovir. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001618 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001618">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">adefovir pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001616"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-12T14:45:31Z</oboInOwl:creation_date>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Adefovir is an anti-viral drug used for the treatment of chronic hepatitis B.</obo:IAO_0000115>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001618</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00418</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001620 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001620">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bisphosphonate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-16T10:18:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001620</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of bisphoshonate drugs that help prevent the loss of bone mass and are used in the treatment of osteoporosis. The two classes - non-nitrogenous and nitrogen-containing drugs, employ different mechanisms to affect osteoclast activity. Bisphosphonates are preferentially taken up by osteoclast cells. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001621 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001621">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nitrogenous bisphosphonate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001620"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-16T10:25:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001621</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of nitrogenous bisphosphate drugs, inhibitors of farnesyl diphosphate synthase. The disruption of geranyl and farnesyl pyrophosphate production affects the cell membrane localization of proteins that depend on this lipid modification for proper placement. They include the members of the small G proteins and the impact on Ras, Rho and Rac G proteins is thought to underlie the effect of drugs.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001622 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001622">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">non-nitrogenous bisphosphonate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001620"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-16T10:26:05Z</oboInOwl:creation_date>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Non-nitrogenous bisphosphonate drugs are metabolized to compounds that render the ATP molecule non-functional, thus promoting cell death.</obo:IAO_0000115>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001622</oboInOwl:id>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001623 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001623">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nitrogenous bisphosphanate pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001621"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-16T11:05:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001623</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of nitrogenous bisphosphonates such as alendronate, ibandronate, pamidronate or risedronate. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001624 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001624">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nitrogenous bisphosphonate pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001621"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-16T11:06:45Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001624</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00079</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00095</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00112</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00117</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of nitrogenous bisphosphonate-target interaction and of the biochemical or physiological responses to them. They include alendronate, ibandronate, pamidronate or risedronate. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001632 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001632">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">alfentanil drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-26T12:43:39Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001632</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of alfentanil - a synthetic opioid used for anesthesia in surgery. The drug is short-acting but potent and classified as restricted. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001633 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001633">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">alfentanil pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001632"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-26T12:51:27Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001633</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of alfentanil. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001634 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001634">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">alfentanil pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001632"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-26T12:52:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001634</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00413</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of alfentanil-target interaction and of the biochemical or physiological responses to drug. The drug is an agonist for mu opioid receptors, is classified as a restrictive drug and is almost exclusively used for anesthesia in surgery. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001635 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001635">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">alteplase drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002152"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-26T13:08:24Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001635</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of alteplase - one of several recombinant tissue plasminogen activators. Plasminogen is a key player in the fibrinolytic cascade pathway of blood clots breakdown. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001636 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001636">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">alteplase pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001635"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-26T13:16:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001636</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of alteplase, one of several recombinant tissue plasminogen activators. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001637 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001637">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">alteplase pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001635"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-26T13:16:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001637</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00280</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of alteplase-target interaction and of the biochemical or physiological responses to drug. Alteplase is one of several recombinant tissue plasminogen activators. Alteplase is used for treatment of myocardial infarction and ischemic stroke, among others. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001638 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001638">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amiloride drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-26T15:23:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001638</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of amiloride - a blocker of epithelial sodium channels used for the treatment of hypertension and congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001639 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001639">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amiloride pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001638"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-26T15:23:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001639</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of amiloride. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001640 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001640">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amiloride pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001638"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-02-26T15:23:37Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001640</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00133</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of amiloride-target interaction and of the biochemical or physiological responses to drug. The drug blocks the epithelial sodium channels and is used in the treatment of hypertension and congestive heart failure. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001651 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001651">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">antithrombotic drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000922"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-04T15:12:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001651</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent the formation of blood clots.  They are further classified depending on the blood clotting processes they affect. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">anticoagulant drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001652 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001652">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">antihemorrhagic drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000922"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-04T15:26:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001652</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent bleeding. It is to be noted here that genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hemostatic drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001653 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001653">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">aminocaproic acid drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001652"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-04T15:28:59Z</oboInOwl:creation_date>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">6-aminohexanoic acid drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001653</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of aminocaproic acid, an inhibitor of enzymes involved in fibrinolysis and as such, effective in the treatment of certain bleeding disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001654 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001654">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">aminocaproic acid pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001653"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-04T15:34:33Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001654</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of aminocaproic acid. The drug is used in the treatment of certain bleeding disorders. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001655 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001655">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">aminocaproic acid pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001653"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-04T15:37:06Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001655</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00286</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of aminocaproic acid-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001656 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001656">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amiodarone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002336"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-04T15:44:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001656</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of amiodarone, a drug used in the treatment of arrhythmia. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001657 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001657">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amiodarone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001656"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-05T12:07:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001657</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of amiodarone. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001658 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001658">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amiodarone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001656"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-05T12:07:31Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001658</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00665</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of amiodarone-target interaction and of the biochemical or physiological responses to drug. Amiodarone has beta blocker-like and calcium channel blocker-like actions. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001659 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001659">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amlodipine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001894"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-09T15:06:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001659</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of amlodipine, a calcium channel blocker used to lower blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001660 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001660">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amlodipine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001659"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-09T15:11:02Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001660</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of amlodipine, a calcium channel blocker. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001661 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001661">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">amlodipine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001659"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-09T15:14:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001661</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00376</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of amlodipine-target interaction and of the biochemical or  physiological responses to drug. Amlodipine, a calcium channel blocker is used to lower blood pressure. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001662 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001662">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">anistreplase drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002152"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-09T15:22:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001662</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of anistreplase, an antithrombic drug that converts plasminogen to the active plasmin which degrades fibrin (blood clots). Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001663 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001663">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">anistreplase pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001662"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-09T15:42:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001663</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of anistreplase. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001664 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001664">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">anistreplase pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001662"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-09T15:43:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001664</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00281</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of anistreplase-target interaction and of the biochemical or physiological responses to drug. An anithrombic drug, anistreplase cleaves a bond in plasminogen to form plasmin. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001665 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001665">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">antipyrine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001546"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-09T15:53:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001665</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00692</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics/pharmacodynamics of anitpyrine, an analgesic and antipyretic drug used to relieve pain and fever.  It is thought to inhibit prostaglandin biosynthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001666 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001666">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">antipyrine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001665"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-03-09T16:10:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001666</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of antipyrine, a drug used to relieve pain and fever. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001672 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001672">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vinca alkaloid drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T09:10:31Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001672</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vinca alkaloids are anti-mitotic and anti-microtubule agents originally derived from plants and also produced as semisynthetic compounds. They have a hypoglycemic and cytotoxic effects and are widely used as cancer drugs.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001673 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001673">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vinblastine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001672"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T09:20:40Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001673</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of vinblastine - a vinca alkaloid used as anticancer agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VBL drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001674 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001674">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vinorelbine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001672"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T09:23:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001674</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of vinorelbine - a vinca alkaloid used as anticancer agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VRL drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001675 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001675">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vincristine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001672"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T09:24:59Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001675</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of vincristine - a vinca alkaloid used as anticancer agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VCR drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001676 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001676">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vindesine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001672"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T09:26:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001676</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of vindesine - a vinca alkaloid used as anticancer agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VDS drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001677 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001677">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vinblastine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001673"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T09:35:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001677</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of vinblastine, an anti-mitotic, anticancer agent. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VBL pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001678 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001678">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vinblastine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001673"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T09:35:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001678</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00436</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of vinblastine-target interaction and of the biochemical or physiological responses to drug. The drug interacts with tubulin and disrupts microtubules function, particularly those at the mitotic spindle. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VBL pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001679 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001679">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vincristine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001675"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T09:35:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001679</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of vincristine, an anti-mitotic, anticancer agent. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VCR pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001680 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001680">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vincristine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001675"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T09:36:10Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001680</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00437</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of vincristne-target interaction and of the biochemical or physiological responses to drug. The drug interacts with tubulin and disrupts microtubules function, particularly those at the mitotic spindle. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VCR pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001681 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001681">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vindesine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001676"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T09:36:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001681</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of vindesine, an anti-mitotic, anticancer agent. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VDS pharmacokientics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001682 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001682">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vindesine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001676"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T09:37:09Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001682</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00438</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of vindesine-target interaction and of the biochemical or physiological responses to drug. The drug interacts with tubulin and disrupts microtubules function, particularly those at the mitotic spindle. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VDS pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001683 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001683">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vinorelbine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001674"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T09:38:24Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001683</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of vinorelbine, an anti-mitotic, anticancer agent. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VRL pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001684 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001684">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vinorelbine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001674"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T09:39:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001684</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00439</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of vinorelbine-target interaction and of the biochemical or physiological responses to drug. The drug interacts with tubulin and disrupts microtubules function, particularly those at the mitotic spindle. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VRL pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001685 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001685">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">verapamil drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001893"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T10:39:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001685</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of verapamil - an L-type calcium channel blocker of the phenylalkylamine class. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001686 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001686">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">verapamil pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001685"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T10:42:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001686</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of verapamil, an L-type calcium channel blocker used for the treatment of cardiovascular conditions. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001687 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001687">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">verapamil pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001685"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T10:43:10Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001687</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00375</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of verapamil-target interaction and of the biochemical or physiological responses to drug. The drug is an L-type calcium channel blocker used in the treatment of hypertension and other cardiovascular conditions. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001688 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001688">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">valsartan drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001789"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T10:49:35Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001688</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of valsartan, an angiotensin II receptor type 1 antagonist used in the treatment of high blood pressure and congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001689 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001689">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">valsartan pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001688"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T10:50:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001689</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00165</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of valsartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001690 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001690">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">valsartan pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001688"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-05-08T10:50:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001690</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of valsartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001694 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001694">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">valdecoxib drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-02T14:19:37Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001694</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of valdecoxib, a non-steroidal anti-inflammatory drug used in the treatment of osteoarthritis, rheumatoid arthritis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001695 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001695">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">valdecoxib pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001694"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-02T14:22:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001695</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of valdecoxib, an antirheumatic drug. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001696 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001696">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">valdecoxib pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001694"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-02T14:23:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001696</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00116</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of valdecoxib-target interaction and of the biochemical or physiological responses to drug. The drug is a selective cyclooxygenase-2 inhibitor. Currently, the prodrug parecoxib is being used as valdecoxib has been removed from the market because its side effects risks.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001707 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001707">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">enalapril drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T11:07:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001707</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of enalapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001708 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001708">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">enalapril pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001230"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001707"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T11:08:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001708</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00593</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of enalapril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001709 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001709">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">enalapril pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001231"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001707"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T11:08:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001709</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00148</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of enalapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001710 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001710">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ramipril drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T11:32:35Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001710</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of ramipril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001711 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001711">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ramipril pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001230"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001710"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T11:35:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001711</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00597</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of ramipril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001712 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001712">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ramipril pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001231"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001710"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T11:35:53Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001712</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00154</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ramipril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001713 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001713">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">quinapril drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T11:42:25Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001713</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of quinapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001714 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001714">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">quinapril pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001230"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001713"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T11:42:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001714</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00596</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of quinapril, an ACE inhibitor. Quinapril is a prodrug that is converted to its active  metabolite, quinaprilat, in the liver. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001715 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001715">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">quinapril pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001231"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001713"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T11:43:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001715</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00153</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of quinapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001716 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001716">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">perindopril drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:06:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001716</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of perindopril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001717 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001717">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">perindopril pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001230"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001716"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:07:06Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001717</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of perindopril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001718 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001718">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">perindopril pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001231"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001716"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:07:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001718</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00152</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of perindopril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001719 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001719">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lisinopril drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:12:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001719</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of lisinopril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001720 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001720">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lisinopril pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001231"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001719"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:13:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001720</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00150</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of lisinopril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001721 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001721">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lisinopril pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001230"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001719"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:14:14Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001721</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of lisinopril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001722 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001722">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">benazepril drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:16:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001722</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of benazepril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001723 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001723">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">benazepril pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001230"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001722"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:17:37Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001723</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00591</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of benazepril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001724 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001724">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">benazepril pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001231"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001722"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:18:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001724</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00145</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of benazepril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001725 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001725">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">trandolapril drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:22:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001725</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of trandolapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001726 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001726">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">trandolapril pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001230"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001725"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:23:39Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001726</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00599</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of trandolapril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001727 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001727">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">trandolapril pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001231"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001725"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:24:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001727</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00157</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of trandolapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001728 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001728">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cilazapril drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:29:14Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001728</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of cilazapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001729 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001729">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cilazapril pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001230"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001728"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:30:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001729</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00592</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of cilazapril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001730 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001730">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cilazapril pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001231"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001728"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-05T13:31:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001730</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00147</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of cilazapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001731 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001731">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ticlopidine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002150"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-09T15:59:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001731</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of ticlopidine, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001732 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001732">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ticlopidine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001731"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-09T16:01:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001732</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00611</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of ticlopidine, a platelet aggregation inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001733 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001733">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ticlopidine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001731"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-09T16:02:09Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001733</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00261</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ticlopidine-interaction and of the biochemical or physiological responses to drug. The drug can irreversibly block the adenosine diphosphate (ADP) receptor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001735 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001735">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">adrenergic beta receptor antagonist drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000920"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T09:46:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001735</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of adrenergic beta receptors blockers. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta receptor antagonists are used to inhibit these responses and they are either selective or non-selective. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001737 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001737">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">adrenergic beta receptor selective antagonist drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001735"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T09:58:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001737</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of selective adrenergic beta receptors blockers. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta-1 receptor antagonists are used to inhibit these responses. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001738 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001738">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">adrenergic beta receptor non-selective antagonist drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001735"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T09:59:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001738</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of non-selective adrenergic beta receptors blockers. Adrenergic beta receptors, in response to epinephrine or norepinephrine couple to the Gs alpha subunit of heterotrimeric G protein to elicit several responses. Beta receptor antagonists are used to inhibit these responses. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001739 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001739">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">timolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001738"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T10:07:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001739</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of timolol - a non-selective adrenergic beta receptor blocker. It binds and inhibits the beta 1 receptor and is used in for the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001740 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001740">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">timolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001739"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T10:09:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001740</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of timolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001741 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001741">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">timolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001739"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T10:09:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001741</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00659</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of timolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta 1. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001742 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001742">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tirofiban drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002150"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T10:22:21Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001742</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of tirofiban, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001743 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001743">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tirofiban pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001742"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T10:22:51Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001743</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of tirofiban, a platelet aggregation inhibitor.  Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001744 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001744">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tirofiban pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001742"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T10:23:14Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001744</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00267</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of tirofiban-interaction and of the biochemical or physiological responses to drug. Tirofiban is a reversible inhibitor of glycoprotein IIb/IIIa. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001745 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001745">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tobramycin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T10:30:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001745</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of tobramycine - an anti-bacterial antibiotic, used primarily for the treatment of Gram-negative infections. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001746 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001746">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tobramycin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001745"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T10:30:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001746</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of tobramycin - an antibiotic that interferes with bacterial protein synthesis. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001747 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001747">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tobramycin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001745"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T10:30:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001747</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00711</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of tobramycin-target interaction and of the biochemical or physiological responses to drug. Kanamycin interferes with bacterial protein synthesis and is used in the treatment of Gram-negative infections. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001748 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001748">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tolmetin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T10:46:51Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001748</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of tolmetin, a non-steroidal anti-inflammatory drug used in the treatment of osteoarthritis, rheumatoid arthritis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001749 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001749">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tolmetin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001748"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T10:47:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001749</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of tolmetin, an antirheumatic drug. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001750 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001750">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tolmetin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001748"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-06-12T10:47:22Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001750</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00704</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of tolmetin-target interaction and of the biochemical or physiological responses to drug. Tolmetin is thought to inhibit cyclooxygenases and thus block prostaglandin synthesis. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001768 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001768">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">docetaxel drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-03T15:18:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001768</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of docetaxel - an antineoplastiic agent. It is an anti-mitotic drug whose cytotoxicity affects tumor cells but can also extend to other dividing cells. In some cases, the drug could cause severe side effects and deaths due to its toxicity have been reported. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001769 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001769">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">docetaxel pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001768"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-03T15:25:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001769</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of docetaxel. Docetaxel is used as a chemotherapeutic agent for the treatment of various cancers. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001770 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001770">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">docetaxel pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001768"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-03T15:25:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001770</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00435</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of docetaxel-target interaction and of the biochemical or physiological responses to drug. Docetaxel  is used as a chemotherapeutic agent for the treatment of various cancers. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001771 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001771">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tenofovir drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-03T15:46:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001771</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of tenofovir, an antirfetroviral drug used for the treatment of HIV infection and hepatitis B. It is a nucleoside analog reverse transcriptase inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001772 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001772">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tenofovir pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001771"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-03T15:46:14Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001772</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00630</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of tenofovir - a nucleotide analogue reverse transcriptase inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001773 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001773">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tenofovir pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001771"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-03T15:46:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001773</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00419</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of tenofovir-target interaction and of the biochemical or physiological responses to drug. Tenofovir is a nucleotide analogue reverse transcriptase inhibitor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001786 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001786">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tranexamic acid drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001652"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T13:41:25Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001786</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of tranexamic acid, an inhibitor of enzymes involved in fibrinolysis and as such, effective in the treatment of certain bleeding disorders It is also used in surgery to prevent excessive bleeding. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001787 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001787">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tranexamic acid pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001786"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T13:43:10Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001787</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of tranexamic acid. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001788 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001788">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tranexamic acid pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001786"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T13:43:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001788</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00287</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of tranexamic acid-target interaction and of the biochemical or physiological responses to drug. It is an inhibitor of plasminogen and used to treat bleeding conditions and in surgery to prevent excessive bleeding  Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001789 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001789">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">renin-angiotensin system drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000920"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T14:22:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001789</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of drugs that target the renin-angiotensin system, such as ACE inhibitors and angiotensin II antagonists.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001790 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001790">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">triamterene drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000920"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T14:37:45Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001790</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of triamterene, a sodium channel blocker used to lower blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001791 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001791">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">triamterene pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001790"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T14:39:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001791</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of triamterene. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001792 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001792">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">triamterene pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001790"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T14:39:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001792</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00132</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of triamterene-target interaction and of the biochemical or physiological responses to drug. The drug blocks the epithelial sodium channels and is used in the treatment of hypertension. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001793 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001793">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tenoxicam drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T14:58:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001793</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of tenoxicam, a non-steroidal anti-inflammatory drug used in the treatment of osteoarthritis, rheumatoid arthritis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001794 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001794">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tenoxicam pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001793"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T14:58:38Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001794</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of tenoxicam, an antirheumatic drug. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001795 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001795">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tenoxicam pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001793"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T14:59:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001795</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00706</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of tenoxicam-target interaction and of the biochemical or physiological responses to drug. Tenoxicam is thought to inhibit cyclooxygenases and thus block prostaglandin synthesis. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001796 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001796">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">telmisartan drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001789"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T15:06:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001796</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of telmisartan, an angiotensin II receptor type 1 antagonist used in the treatment of essential hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001797 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001797">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">telmisartan pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001796"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T15:06:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001797</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of telmisartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001798 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001798">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">telmisartan pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001796"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T15:07:26Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001798</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00164</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of telmisartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001799 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001799">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sulindac drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T15:18:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001799</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of sulindac, a non-steroidal anti-inflammatory drug used in the treatment of acute or chronic inflammatory conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001800 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001800">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sulindac pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001799"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T15:18:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001800</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of sulindac, an anti-inflammatory drug. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001801 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001801">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sulindac pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001799"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-10T15:19:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001801</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00094</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of sulindac-target interaction and of the biochemical or physiological responses to drug. Sulindac is thought to interfere with prostaglandin synthesis.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001803 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001803">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">streptomycin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-19T15:13:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001803</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of streptomycin, a bactericidal antibiotic that inhibits bacterial protein synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001804 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001804">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">streptomycin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001803"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-19T15:17:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001804</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00259</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Streptomycin inhibits bacterial protein synthesis in both Gram-positive and Gram-negative bacteria and as such is a broad-spectrum antibiotic.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001819 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001819">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">stavudine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-20T10:07:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001819</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of stavudine, an anti-viral drug used for the treatment of HIV infection. It belongs to the family of nucleoside analog reverse transcriptase inhibitors. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001820 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001820">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">stavudine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001819"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-20T10:09:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001820</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of stavudine, a drug used for the treatment of HIV. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001821 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001821">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">stavudine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001819"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-20T10:09:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001821</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00745</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of stavudine-target interaction and of the biochemical or physiological responses to drug. Stavudine is a drug used for the treatment of HIV infection. Stavudine, in its active triphosphate form, inhibits HIV-1 reverse transcriptase activity. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001822 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001822">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">spironolactone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-20T10:29:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001822</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of spironolactone - a drug used in the treatment of hypertension and heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001823 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001823">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">spironolactone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001822"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-20T10:29:27Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001823</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of spironolactone. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001824 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001824">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">spironolactone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001822"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-20T10:29:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001824</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00134</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of spironolactone-target interaction and of the biochemical or physiological responses to drug. The drug inhibits the effects of aldosterone by competing with its receptor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001825 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001825">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">spirapril drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-20T10:49:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001825</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of spirapril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001826 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001826">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">spirapril pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001230"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001825"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-20T10:50:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001826</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00598</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of spirapril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001827 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001827">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">spirapril pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001231"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001825"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-20T10:50:24Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001827</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00156</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of spirapril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001828 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001828">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sotalol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001738"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-20T11:09:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001828</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of sotalol - a non-selective adrenergic beta receptor blocker. It binds and inhibits the beta 1 and beta 2 receptors and is used for the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001829 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001829">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sotalol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001828"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-20T11:10:35Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001829</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00660</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of sotalol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta 1 and beta 2. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001830 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001830">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sotalol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001828"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-20T11:11:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001830</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of sotalol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001834 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001834">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">roxatidine acetate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000921"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-24T15:00:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001834</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of roxatidine acetate - a histamine H2 specific receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001835 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001835">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">roxatidine acetate pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001834"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-24T15:03:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001835</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of roxatidine. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001836 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001836">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">roxatidine acetate pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001834"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-24T15:03:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001836</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00734</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of roxatidine-target interaction and of the biochemical or physiological responses to drug. The drug is a specific antagonist H2 receptor and it is used for the treatment of various acid disorders. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001837 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001837">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">risedronate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001621"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-24T15:20:24Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001837</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of risedronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001838 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001838">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">risedronate pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001624"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001837"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-24T15:25:37Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001838</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00112</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of risedronate-target interaction and of the biochemical or physiological responses to drug. Risedronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001839 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001839">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">risedronate pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001623"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001837"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-24T15:25:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001839</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of risedronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001843 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001843">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ranitidine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000921"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-28T10:10:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001843</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of ranitidine acetate - a histamine H2 specific receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001844 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001844">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ranitidine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001843"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-28T10:12:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001844</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of ranitidine. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001845 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001845">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ranitidine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001843"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-28T10:12:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001845</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00230</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ranitidine-target interaction and of the biochemical or physiological responses to drug. The drug is a specific antagonist H2 receptor and it is used for the treatment of various acid disorders. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001846 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001846">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">rabeprazole drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000918"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-28T10:19:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001846</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of rabeprazole, a proton pump inhibitor. It is administered for the treatment of acid-related disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001847 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001847">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">rabeprazole pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001846"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-28T10:22:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001847</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00616</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of rabeprazole, a compound in the class of proton pump inhibitors. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001848 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001848">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">rabeprazole pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001846"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-28T10:22:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001848</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00229</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of rabeprazole-target interaction and of the biochemical or physiological responses to drug. Rabeprazole is a compound in the class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001849 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001849">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">quinidine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002336"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-28T12:49:25Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001849</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of quinidine, a class I antiarrhythmic agent that can increase cardiac action potential. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001850 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001850">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">quinidine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001849"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-28T13:01:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001850</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of quinidine, a class I antiarrhythmic agent. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001851 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001851">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">quinidine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001849"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-08-28T13:02:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001851</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00323</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of quinidine-target interaction and of the biochemical or physiological responses to drug. Its primary action is blocking the fast inward sodium current. However, it can impact on other currents and channels, such as the slow inward calcium, the rapid and slow components of the delayed potassium, and the inward potassium rectifier currents, and the ATP-sensitive potassium channel. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001852 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001852">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">propranolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001738"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T10:17:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001852</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of propanolol - a non-selective adrenergic beta receptor blocker, used for the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001853 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001853">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">propranolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001852"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T10:17:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001853</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of propanolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001854 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001854">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">propranolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001852"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T10:18:20Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001854</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00307</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of propanolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001855 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001855">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">procaine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002243"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T10:27:50Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001855</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of procaine, a drug used as a local anesthetic. It also has anti--inflammatory and mood enhancing effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">novocaine drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001856 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001856">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">procaine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001855"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T10:31:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001856</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of procaine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">novocaine pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001857 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001857">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">procaine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001855"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T10:32:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001857</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00402</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of procaine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">novocaine pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001858 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001858">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">procainamide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002336"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T10:40:14Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001858</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of procainamide, a class Ia antiarrhythmic drug. There are many adverse side effects and the cytotoxicity of the drug is documented. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001859 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001859">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">procainamide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001858"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T10:47:25Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001859</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of procainamide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001860 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001860">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">procainamide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001858"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T10:47:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001860</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00324</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of procainamide-target interaction and of the biochemical or physiological responses to drug. The drug is a class Ia antiarrhythmic drug that can also elicit serious cytotoxic effects.  Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001862 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001862">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">prednisone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000921"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001203"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002369"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T11:08:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001862</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of prednisone - a synthetic glucocorticoid that is particularly effective as a immunosuppressant drug. Both short- and long-term effects can occur. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001863 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001863">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">prednisone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001862"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T11:11:33Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001863</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00631</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of prednisone, a synthetic glucocorticoid. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001864 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001864">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">prednisone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001862"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T11:12:03Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001864</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00440</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of prednisone-target interaction and of the biochemical or physiological responses to drug. The drug is particularly effective as an immunosuppressant. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001865 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001865">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">piroxicam drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T12:07:27Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001865</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of piroxicam, a non-steroidal anti-inflammatory drug used in the treatment of inflammatory conditions and to relieve pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001866 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001866">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">piroxicam pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001865"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T12:08:24Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001866</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of piroxicam, an anti-inflammatory drug. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001867 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001867">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">piroxicam pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001865"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-01T12:09:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001867</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00077</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of piroxicam-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective cyclooxygenase (COX) inhibitor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001882 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001882">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pirenzepine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000921"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-02T13:55:25Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001882</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of pirenzepine, a muscarinic receptor antagonist used in the treatment of peptic ulcers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001883 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001883">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pirenzepine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001882"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-02T14:09:38Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001883</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of pirenzepine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001884 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001884">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pirenzepine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001882"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-02T14:10:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001884</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00246</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of pirenzepine-target interaction and of the biochemical or physiological responses to drug.  Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001885 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001885">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pentazocine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-02T14:34:35Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001885</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of pentazocine, an opioid analgesic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001886 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001886">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pentazocine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001885"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-02T14:38:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001886</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of pentazocine, an opioid analgesic. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001887 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001887">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pentazocine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001885"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-02T14:38:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001887</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00686</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of pentazocine-target interaction and of the biochemical or physiological responses to drug. Pentazocine is an opioid analgesic used to treat moderate to more severe pain. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001888 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001888">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pantoprazole drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000918"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-02T15:07:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001888</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of pantoprazole, a proton pump inhibitor. It is administered for the treatment of acid-related disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001889 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001889">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pantoprazole pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001888"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-02T15:08:25Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001889</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00615</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of pantoprazole, a compound in the class of proton pump inhibitors. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001890 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001890">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pantoprazole pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001888"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-02T15:09:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001890</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00228</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of pantoprazole-target interaction and of the biochemical or physiological responses to drug. Pantoprazole is a compound in the class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001891 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001891">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">streptomycin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001803"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-02T15:31:20Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001891</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of streptomycin - an antibiotic that interferes with bacterial protein synthesis. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001892 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001892">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">calcium channel blocker drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000920"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T10:14:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001892</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of calcium channel blockers - agents used as antihypertensive drugs. They are further classified as dihydropyridine and non-dihydropyridine drugs, and both classes are rather selective. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001893 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001893">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">non-dihydropyridine calcium channel blocker drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001892"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T10:31:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001893</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of non-dihydropyridine calcium channel blockers - agents often used to treat angina and relatively selective for myocardium. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001894 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001894">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dihydropyridine calcium channel blocker drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001892"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T10:31:33Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001894</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of dihydropyridine calcium channel blockers - agents derived from dihydropyridine and used to reduce arterial pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001895 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001895">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nimodipine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001894"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T10:48:59Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001895</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of nimodipine, a calcium channel blocker developed for the treatment of hypertension but now used to prevent vasospasm. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001896 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001896">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nisoldipine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001894"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T10:50:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001896</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of nifedipine, a calcium channel blocker used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001897 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001897">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nitrendipine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001894"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T10:51:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001897</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of nitrendipine, a calcium channel blocker used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001898 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001898">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nimodipine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001895"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T10:54:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001898</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of nimodipine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001899 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001899">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nisoldipine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001896"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T10:54:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001899</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of nisoldipine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001900 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001900">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nitrendipine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001897"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T10:54:51Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001900</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of nitrendipine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001901 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001901">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nimodipine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001895"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T10:55:14Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001901</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00380</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of nimodipine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001902 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001902">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nisoldipine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001896"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T10:55:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001902</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00381</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of nisoldipine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001903 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001903">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nitrendipine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001897"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T10:55:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001903</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00382</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of nitrendipine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001904 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001904">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nizatidine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000921"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T11:32:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001904</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of nizatidine - a histamine H2 specific receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001905 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001905">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nizatidine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001904"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T11:33:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001905</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of nizatidine. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001906 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001906">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nizatidine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001904"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T11:34:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001906</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00233</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of nizatidine-target interaction and of the biochemical or physiological responses to drug. The drug is a histamine H2 receptor specific antagonist used for the treatment of various acid disorders. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001907 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001907">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">olmesartan drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001789"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T11:42:02Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001907</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of olmesartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001908 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001908">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">olmesartan pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001907"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T11:42:20Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001908</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of olmesartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001909 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001909">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">olmesartan pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001907"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T11:42:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001909</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00163</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of olmesartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001910 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001910">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nebivolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001737"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T12:21:35Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001910</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of nebivolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001911 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001911">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nebivolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001910"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T12:22:06Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001911</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of nebivolol. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001912 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001912">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nebivolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001910"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T12:22:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001912</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00366</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of nebivolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001913 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001913">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">naproxen drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001202"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001546"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T12:33:24Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001913</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of naproxen, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and is used in the treatment of inflammation and pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001914 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001914">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">naproxen pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001913"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T12:33:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001914</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of naproxen. The drug is used in the treatment of pain and inflammation. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001915 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001915">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">naproxen pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001913"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T12:34:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001915</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00120</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of naproxen-target interaction and of the biochemical or physiological responses to drug. Naproxen is an inhibitor of cyclooxygenase enzymes used in the treatment of pain and inflammation. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001916 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001916">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">naltrexone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T12:42:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001916</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of naltrexone, an antagonist of opioid receptors used in the treatment of substance dependence. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001917 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001917">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">naltrexone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001916"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T12:43:21Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001917</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of naltrexone, an antagonist of opioid receptors. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001918 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001918">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">naltrexone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001916"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T12:43:53Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001918</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00687</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of naltrexone-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of mu opioid receptor and to a lesser and much lesser extent, the kappa and delta opioid receptors, respectively. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001919 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001919">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nalbuphine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T13:11:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001919</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of nalbuphine, a semi-synthetic opioid used an analgesic for the relief of moderate to severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001920 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001920">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nalbuphine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001919"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T13:29:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001920</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of nalbuphine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001921 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001921">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nalbuphine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001919"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T13:29:06Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001921</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00691</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of nalbuphine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001922 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001922">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nabumetone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T13:44:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001922</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of nabumetone, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes, preferentially COX-2 type. The drug is used in the treatment of inflammation and pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001923 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001923">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nabumetone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001922"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T13:44:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001923</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of nabumetone. The drug is rapidly metabolized in the liver to 6-methoxy-2-naphthyl, its major active metabolite. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001924 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001924">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nabumetone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001922"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T13:45:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001924</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00114</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of nabumetone-target interaction and of the biochemical or physiological responses to drug. Nabumetone is an inhibitor of COX-2 enzyme used in the treatment of pain and inflammation. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001925 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001925">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">metolazone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T14:03:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001925</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of metolazone - a blocker of sodium -chloride symporter in the distal convoluted tubule of the nephron. The drug is used for the treatment of hypertension and congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001926 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001926">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">metolazone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001925"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T14:03:31Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001926</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of metolazone. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001927 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001927">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">metolazone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001925"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T14:04:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001927</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00105</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of metolazone-target interaction and of the biochemical or physiological responses to drug. The drug blocks the sodium-chloride symporter and is used in the treatment of hypertension and congestive heart failure. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001928 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001928">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">metoprolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001737"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T14:34:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001928</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of metoprolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and several other conditions involving a faster than normal heart rate. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001929 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001929">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">metoprolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001928"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T14:35:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001929</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of metoprolol. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001930 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001930">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">metoprolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001928"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-17T14:35:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001930</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00302</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of metoprolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001939 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001939">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">methadone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T14:15:14Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001939</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of methadone, an acyclic analog of morphine and heroin acting on the same opioid receptors and used in the management of severe, chronic pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001940 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001940">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">methadone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001939"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T14:17:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001940</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00624</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of methadone. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001941 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001941">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">methadone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001939"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T14:18:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001941</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00408</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of methadone-target interaction and of the biochemical or physiological responses to drug. Methadone binds the mu-opioid receptor of sensory neurons triggering downstream cascades that activate potassium channels while inactivating calcium channels. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001942 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001942">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mercaptopurine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002369"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T14:28:40Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001942</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of mercaptopurine, an immunosuppressive drug used in the treatment of leukemia, Crohn&#39;s disease and colitis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001943 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001943">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mercaptopurine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001942"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T14:30:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001943</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00609</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of mercaptopurine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001944 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001944">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mercaptopurine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001942"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T14:30:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001944</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00428</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of mercaptopurine-target interaction and of the biochemical or physiological responses to drug. The drug is used as an immunosuppressive and its cytotoxic effects result from its interference with nucleic acids synthesis and function. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001945 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001945">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mepivacaine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002243"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T14:49:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001945</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of mepivacaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001946 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001946">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mepivacaine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001945"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T14:50:59Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001946</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of mepivacaine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001947 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001947">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mepivacaine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001945"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T14:51:24Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001947</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00399</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of mepivacaine-target interaction and of the biochemical or physiological responses to drug. It acts mainly as a blocker of voltage-gated sodium channels. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001948 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001948">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">meloxicam drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T15:10:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001948</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of meloxicam, a non-steroidal anti-inflammatory drug used to relieve pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001949 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001949">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">meloxicam pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001948"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T15:11:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001949</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of piroxicam. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001950 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001950">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">meloxicam pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001948"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T15:11:35Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001950</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00106</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of meloxicam-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective cyclooxygenase (COX) inhibitor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001951 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001951">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mefenamic acid drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T15:17:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001951</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of mefenamic acid, a non-steroidal anti-inflammatory drug used to treat mild to moderate pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001952 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001952">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mefenamic acid pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001951"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T15:18:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001952</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of mefenamic acid. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001953 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001953">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mefenamic acid pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001951"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-22T15:18:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001953</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00109</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of mefenamic acid-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective cyclooxygenase (COX) inhibitor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001963 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001963">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lansoprazole drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000918"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-24T14:41:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001963</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of lansoprazole, a proton pump inhibitor. It is administered for the treatment of acid-related disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001964 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001964">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lansoprazole pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001963"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-24T14:42:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001964</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00614</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of lansoprazole, a compound in the class of proton pump inhibitors pharmacologically related to omeprazole. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001965 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001965">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lansoprazole pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001963"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-24T14:43:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001965</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00227</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of lansoprazole-target interaction and of the biochemical or physiological responses to drug. Lansoprazole is a compound in the class of proton pump inhibitors pharmacologically related to omperazole, used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001966 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001966">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ketorolac drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-24T15:07:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001966</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of ketorolac, a non-steroidal anti-inflammatory drug used to treat moderate to severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001967 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001967">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ketorolac pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001966"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-24T15:11:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001967</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of ketorolac. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001968 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001968">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ketorolac pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001966"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-24T15:11:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001968</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00098</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ketorolac-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective cyclooxygenase (COX) inhibitor used for short-term management of moderate to severe pain. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001969 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001969">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ketoprofen drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001546"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-24T15:23:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001969</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of ketoprofen, a non-steroidal anti-inflammatory drug that also has analgesic and antipyretic effects. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001970 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001970">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ketoprofen pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001969"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-24T15:27:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001970</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of ketoprofen. The drug is used in the treatment of inflammation and pain. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001971 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001971">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ketoprofen pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001969"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-24T15:27:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001971</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00085</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ketoprofen-target interaction and of the biochemical or physiological responses to drug. Ketoprofen is an inhibitor of cyclooxygenase enzymes used in the treatment of inflammation and pain. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001972 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001972">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">isradipine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001894"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-24T15:45:27Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001972</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of isradipine, a calcium channel blocker used for the treatment of high blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001973 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001973">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">isradipine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001972"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-24T15:46:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001973</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of isradipine. The drug is a calcium channel blocker used in the treatment of high blood pressure.  Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001974 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001974">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">isradipine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001972"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-24T15:46:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001974</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00378</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of isradipine-target interaction and of the biochemical or physiological responses to drug. The drug is a calcium channel blocker, particularly the L-type channel, used for the treatment of high blood pressure.  Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001982 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001982">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">irbesartan drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001789"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-28T15:08:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001982</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of irbesartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Irbesartan is one of several angiotensin II receptor antagonists.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001983 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001983">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">irbesartan pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001982"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-28T15:11:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001983</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of irbesartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001984 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001984">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">irbesartan pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001982"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-28T15:11:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001984</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00161</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of irbesartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001985 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001985">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">imipramine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002113"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-28T15:24:56Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001985</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of imipramine, an antidepressant used in the treatment of major depression. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001986 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001986">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">imipramine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001985"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-28T15:27:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001986</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00625</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of imipramine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001987 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001987">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">imipramine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001985"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-28T15:28:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001987</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00422</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of imipramine-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depression and its effect results from inhibition of serotonin and norepinephrine neurotransmitter reuptake. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001988 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001988">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ibutilide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002336"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-28T15:52:56Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001988</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of ibutilide, an antiarrhythmic agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001989 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001989">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ibutilide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001988"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-28T15:54:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001989</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of ibutilide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0001990 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0001990">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ibutilide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001988"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-09-28T15:55:26Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001990</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00332</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ibutilide-target interaction and of the biochemical or physiological responses to drug. The drug is an antiarrhythmic agent. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002000 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002000">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ibandronate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001621"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-01T14:58:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002000</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of ibandronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002001 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002001">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ibandronate pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001623"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001624"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002000"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-01T15:00:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002001</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of ibandronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002002 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002002">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ibandronate pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002000"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-01T15:01:20Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002002</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00079</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ibandronate-target interaction and of the biochemical or physiological responses to drug. Ibandronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002003 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002003">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hydrochlorothiazide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-01T15:18:39Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002003</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of hydrochlorothiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002004 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002004">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hydrochlorothiazide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002003"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-01T15:25:14Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002004</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of hydrochlorothiazide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002005 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002005">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hydrochlorothiazide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002003"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-01T15:25:40Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002005</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00100</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of hydrochlorothiazide-target interaction and of the biochemical or physiological responses to drug. The drug reduces sodium reabsorption in the distal convoluted tubule of kidney nephron. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002006 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002006">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gliclazide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000723"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-01T15:51:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002006</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of gliclazide, a second generation sulfonylurea anti-diabetic drug used in the treatment of type 2 diabetes mellitus. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002007 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002007">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gliclazide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002006"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-01T15:51:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002007</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of gliclazide, an anti-diabetic drug used in the treatment of type 2 diabetes mellitus. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002008 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002008">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gliclazide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002006"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-01T15:52:31Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002008</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00461</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of gliclazide-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of type 2 diabetes mellitus. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002009 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002009">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">glyburide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000723"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-02T12:51:10Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002009</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of glyburide, a second generation sulfonylurea anti-diabetic drug used in the treatment of type 2 diabetes mellitus. The drug is also known as glibenclamide. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">glibenclamide drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002010 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002010">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">glyburide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002009"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-02T12:53:26Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002010</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of glyburide, an anti-diabetic drug used in the treatment of type 2 diabetes mellitus. The drug is also known is glibenclamide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">glibenclamide pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002011 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002011">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">glyburide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002009"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-02T12:54:21Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002011</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00460</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of glyburide-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of type 2 diabetes mellitus. Glyburide is also known as glibenclamide. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">glibenclamide pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002012 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002012">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gentamicin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001433"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-02T13:01:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002012</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of gentamicin - an antibiotic that interferes with bacterial protein synthesis. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002013 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002013">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gentamicin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001433"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-02T13:01:25Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002013</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00254</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of gentamicin-target interaction and of the biochemical or physiological responses to drug. Gentamicin interferes with bacterial protein synthesis and is used in the treatment of several infections caused by both Gram-negative and Gram-positive bacteria. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002014 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002014">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">furosemide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-02T13:13:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002014</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of furosemide - a blocker of luminal sodium-potassium-chloride symporter used for the treatment of hypertension and edema. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002015 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002015">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">furosemide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002014"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-02T13:13:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002015</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of furosemide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002016 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002016">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">furosemide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002014"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-02T13:13:35Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002016</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00115</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of furosemide-target interaction and of the biochemical or physiological responses to drug. The drug blocks the luminal sodium-potassium-chloride symporter in the thick ascending limb of the loop of Henle. Furosemide is used in the treatment of hypertension and edema.  Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002022 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002022">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fosinopril drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-07T15:23:24Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002022</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of fosinopril - an angiotensin converting enzyme (ACE) inhibitor used for the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002023 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002023">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fosinopril pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002022"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-07T15:23:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002023</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00594</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of fosinopril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002024 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002024">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fosinopril pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001231"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002022"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-07T15:24:20Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002024</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00149</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of fosinopril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002025 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002025">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">forasartan drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001789"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-07T15:29:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002025</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of forasartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002026 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002026">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">forasartan pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002025"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-07T15:30:27Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002026</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of forasartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002027 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002027">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">forasartsn pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002025"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-07T15:30:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002027</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00160</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of forasartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002028 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002028">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fluoxetine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002115"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-07T15:41:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002028</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of fluoxetine, an antidepressant used in the treatment of major depressive disorders. The drug is a selective serotonin reuptake inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002029 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002029">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fluoxetine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002028"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-07T15:43:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002029</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00646</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of fluoxetine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002030 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002030">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fluoxetine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002028"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-07T15:43:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002030</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00426</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of fluoxetine-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depressive disorders and its effect results from selective inhibition of serotonin reuptake. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002031 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002031">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">flecainide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002336"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-08T14:41:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002031</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of flecainide, a drug used in the treatment of cardiac arrhythmias. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002032 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002032">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">flecainide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002031"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-08T14:42:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002032</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of flecainide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002033 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002033">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">flecainde pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002031"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-08T14:42:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002033</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00331</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of flecainide-target interaction and of the biochemical or physiological responses to drug. The drug is an antiarrhythmic agent that acts by blocking sodium and possibly other channels in cardiomyocytes. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002034 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002034">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fentanyl drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-08T14:55:41Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002034</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of fentanyl, a potent opioid analgesic used to treat sudden, severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002035 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002035">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fentanyl pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002034"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-08T14:56:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002035</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of fentanyl, a potent opioid analgesic. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002036 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002036">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fentanyl pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002034"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-08T14:56:56Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002036</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00415</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of fentonyl-target interaction and of the biochemical or physiological responses to drug. The drug is a synthetic opioid analgesic acting as a strong inhibitor of mu receptors. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002037 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002037">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">famotidine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000921"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-08T15:28:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002037</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of famotidine - a histamine H2 receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002038 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002038">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">famotidine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002037"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-08T15:29:39Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002038</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of famotidine. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002039 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002039">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">famotidine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002037"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-08T15:30:03Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002039</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00231</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of famotidine-target interaction and of the biochemical or physiological responses to drug. The drug is a histamine H2 receptor antagonist used in the treatment of acid disorders. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002040 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002040">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">etodolac drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-08T15:37:06Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002040</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of etodolac, a non-steroidal anti-inflammatory drug used in the treatment of mild to moderate pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002041 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002041">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">etodolac pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002040"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-08T15:37:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002041</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of etodolac. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002042 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002042">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">etodolac pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002040"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-08T15:38:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002042</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00084</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of etodolac-target interaction and of the biochemical or physiological responses to drug. The drug is a cyclooxygenase (COX) inhibitor with a preference for COX-2 enzyme. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002043 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002043">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">etacryninc acid drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T12:53:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002043</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of etacrinic acid, a loop diuretic used  in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002044 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002044">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">etacrynic acid pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002043"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T12:54:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002044</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of etacrynic acid. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002045 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002045">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">etacrynic acid pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002043"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T12:54:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002045</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00097</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of etacrynic acid-target interaction and of the biochemical or physiological responses to drug. The drug acts by inhibiting sodium-potassium-chloride contransport in the ascending loop of Henle. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002046 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002046">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">esmolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001737"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T13:02:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002046</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of esmolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and several other conditions involving a faster than normal heart rate. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002047 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002047">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">esmolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002046"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T13:03:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002047</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of esmolol. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002048 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002048">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">esmolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002046"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T13:04:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002048</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00301</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of esmolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002049 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002049">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">escitalopram drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002115"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T13:35:53Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002049</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of escitalopram, an antidepressant used in the treatment of major depressive disorders. The drug is a selective serotonin reuptake inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002050 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002050">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">escitalopram pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002049"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T13:36:39Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002050</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of escitalopram. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002051 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002051">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">escitalopram pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002049"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T13:37:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002051</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00425</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of escitalopram-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depressive disorders and its effect results from selective inhibition of serotonin reuptake. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002052 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002052">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">erythromycin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T13:41:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002052</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of erythromycin, an antibiotic that inhibits bacterial growth and used for the treatment of several bacterial infections. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002053 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002053">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">erythromycin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002052"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T13:41:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002053</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of erythromycin - an antibiotic that interferes with bacterial growth. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002054 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002054">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">erythromycin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002052"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T13:43:02Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002054</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00250</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ertthromycin-target interaction and of the biochemical or physiological responses to drug. The drug interferes with bacterial growth via incompletely understood mechanisms. It is used for the treatment of several bacterial infections. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002055 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002055">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">eptifibatide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002150"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T14:39:22Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002055</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of eptifibatide, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002056 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002056">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">eptifibatide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002055"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T14:39:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002056</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of eptifibatide, a platelet aggregation inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002057 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002057">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">eptifibatide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002055"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T14:40:02Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002057</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00266</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of eftifibatide-interaction and of the biochemical or physiological responses to drug. The platelet aggregation inhibitor belongs to glycoprotein IIb/IIIa inhibitor class. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002058 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002058">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">eprosartan drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001789"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T14:51:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002058</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of eprosartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002059 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002059">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">eprosartan pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002058"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T14:51:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002059</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of eprosartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002060 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002060">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">eprosartan pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002058"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-09T14:52:03Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002060</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00159</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of eprosartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002063 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002063">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">disulfiram drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000923"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-13T14:16:26Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002063</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of disulfiram, a drug used in the treatment of chronic alcoholism and also cocaine dependence. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002064 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002064">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">disulfiram pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002063"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-13T14:16:53Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002064</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of disulfiram. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002065 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002065">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">disulfiram pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002063"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-13T14:17:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002065</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00429</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of disulfiram-target interaction and of the biochemical or physiological responses to drug. The drug inhibits the enzyme acetaldehyde dehydrogenase and also appears to prevent the breakdown of dopamine. Disulfiram is used in the treatment of chronic alcoholism and also cocaine dependence. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002066 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002066">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">disopyramide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002336"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-13T14:51:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002066</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of disopyramide, a drug used in the treatment of arrhythmia. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002067 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002067">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">disopyramide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002066"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-13T14:53:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002067</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of disopyramide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002068 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002068">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">disopyramide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002066"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-13T14:54:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002068</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00325</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of disopyramide-target interaction and of the biochemical or physiological responses to drug. The drug is a sodium channel blocker used in the treatment of arrhythmia. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002069 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002069">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dipyridamole drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002150"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-13T15:01:37Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002069</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of dipyridamole, a drug that inhibits the formation of blood clots via inhibition of platelet aggregation. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002070 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002070">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dipyridamole pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002069"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-13T15:02:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002070</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of dipyridamole. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002071 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002071">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dipyridamole pharmacodyamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002069"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-13T15:02:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002071</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00264</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of dipyridamole-target nteraction and of the biochemical or physiological responses to drug. Dipyridamole inhibits he formation of blood clots via inhibition of platelet aggregation. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002076 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002076">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">diltiazem drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001893"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T08:40:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002076</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of diltiazem- a benzothiazepine L-type calcium channel blocker used in the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002077 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002077">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">diltiazem pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002076"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T08:44:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002077</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of diltiazem, an L-type calcium channel blocker used for the treatment of cardiovascular conditions. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002078 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002078">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">diltiazem pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002076"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T08:45:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002078</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00359</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of diltiazem-target interaction and of the biochemical or physiological responses to drug. The drug is an L-type calcium channel blocker used in the treatment of hypertension and other cardiovascular conditions. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002079 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002079">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">diflunisal drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001546"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T08:51:21Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002079</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of diflunisal,  a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and is used in the treatment of inflammation and pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002080 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002080">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">diflunisal pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002079"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T08:53:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002080</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of diflunisal. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002081 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002081">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">diflunisal pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002079"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T08:53:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002081</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00289</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of diflunisal-target interaction and of the biochemical or physiological responses to drug. Diflunisal is an inhibitor of cyclooxygenase enzymes used in the treatment of pain and inflammation. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002082 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002082">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">didanosine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T09:07:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002082</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of didanosine - an antiretroviral drug used in the treatment of HIV infection. It is a reverse transcriptase inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002083 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002083">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">didanosine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002082"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T09:11:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002083</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of didanosine, a drug used for the treatment of HIV. Didanosine triphosphate is the active form of the drug which is intracellularly metabolized. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002084 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002084">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">didanosine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002082"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T09:12:37Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002084</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00739</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of didanosine-target interaction and of the biochemical or physiological responses to drug. Didanosine is a drug used for the treatment of HIV infection. Didanosine, in its active triphosphate form, inhibits HIV-1 reverse transcriptase activity. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002085 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002085">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">diclofenac drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T09:33:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002085</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of diclofenac, a non-steroidal anti-inflammatory drug used to treat arthritis and other joint diseases.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002086 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002086">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">diclofenac pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002085"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T09:37:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002086</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of diclofenac. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002087 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002087">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">diclofenac pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002085"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T09:37:41Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002087</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00093</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of diclofenac-target interaction and of the biochemical or physiological responses to drug. The drug is used for the treatment of various joint diseases and in pain management. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002088 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002088">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">desipramine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002113"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T09:52:53Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002088</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of desipramine, an antidepressant used in the treatment of depression and attention deficit disorder. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002089 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002089">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">desipramine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002088"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T10:01:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002089</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00626</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of desipramine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002090 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002090">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">desipramine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002088"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-21T10:01:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002090</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00423</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of desipramine-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depression and its effect results from inhibition of norepinephrine and to a lesser extent serotonin neurotransmitter reuptake. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002107 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002107">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cyclophosphamide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-27T14:31:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002107</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of  cyclophosphamide, an alkylating agent used in the treatment of certain cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002108 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002108">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cyclophosphamide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002107"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-27T14:31:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002108</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00604</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of cyclophosphamide. It is a prodrug that has to be converted to its metabolite - 4-hydroxy cyclophosphamide, to exhibit chemotherapeutic activity. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002109 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002109">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cyclophosphamide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002107"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-27T14:33:02Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002109</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00447</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of cyclophosphamide-target interaction and of the biochemical or physiological responses to drug. The alkylating drug is used for the treatment of several cancer types but its toxicity can have severe adverse effects. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002110 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002110">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cimetidine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000921"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-27T14:42:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002110</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of cimetidine - a histamine H2 receptor antagonist used in the treatment of acid disorders. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002111 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002111">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cimetidine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002110"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-27T14:42:51Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002111</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00617</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of cimetidine. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002112 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002112">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cimetidine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002110"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-27T14:43:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002112</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00232</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of cimetidine-target interaction and of the biochemical or physiological responses to drug. The drug is a histamine H2 receptor antagonist used for the treatment of various acid disorders. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002113 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002113">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">non-selective monoamine reuptake inhibitor drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002114"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-27T14:51:09Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002113</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of non- selective monoamine reuptake inhibitor drugs.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002114 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002114">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">antidepressant drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000923"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-27T14:52:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002114</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used to treat various forms of depression. Some are non-selective monoamine reuptake inhibitors, others are selective serotonin reuptake inhibitors. The category also includes monoamine oxidase inhibitors and drug classified as others.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002115 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002115">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">selective serotonin uptake inhibitor drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002114"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-27T15:02:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002115</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of selective serotonin uptake  inhibitor drugs.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002116 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002116">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">citalopram drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002115"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-27T15:06:39Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002116</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of citalopram, an antidepressant used in the treatment of major depressive disorders. The drug is a selective serotonin reuptake inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002117 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002117">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">citalopram pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002116"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-27T15:07:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002117</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00627</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of citalopram. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002118 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002118">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">citalopram pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002116"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-27T15:07:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002118</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00424</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of citalopram-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of major depressive disorders and its effect results from selective inhibition of serotonin reuptake. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002121 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002121">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">diuretic drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000920"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T11:30:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002121</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of drugs that increase water excretion and are used in the treatment of hypertension, heart failure and certain kidney disorders. They are further categorized by type. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002122 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002122">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">chlorthalidone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T11:40:14Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002122</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of chlorothalidone - a blocker of sodium -chloride symporter in the distal convoluted tubule of the nephron. The drug is used for the treatment of hypertension and also as an adjuvant drug for treating edema. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002123 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002123">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">chlorthalidone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002122"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T12:28:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002123</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of chlorthalidone. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002124 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002124">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">chlorthalidone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002122"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T12:29:10Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002124</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00122</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of chlorthalidone-target interaction and of the biochemical or physiological responses to drug. The drug blocks the sodium-chloride symporter and is used in the treatment of hypertension and as an adjuvant for treating edema. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002125 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002125">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">captopril drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T13:08:06Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002125</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of captopril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002126 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002126">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">captopril pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001230"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002125"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T13:08:35Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002126</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of captopril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002127 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002127">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">captopril pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001231"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002125"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T13:09:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002127</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00146</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of captopril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and also for other cardiovascular and kidney diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002128 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002128">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">candesartan drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001789"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T13:42:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002128</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of candsartan, an angiotensin II receptor type 1 antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002129 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002129">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">candesartan pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002128"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T13:43:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002129</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of candesartan. The drug is an antagonist of angiotensin II receptor type 1. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002130 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002130">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">candesartan pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002128"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T13:43:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002130</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00158</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of candesartan-target interaction and of the biochemical or physiological responses to drug. The drug is an antagonist of the angiotensin II receptor type 1. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002131 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002131">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">capecitabine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T14:00:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002131</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of capecitabine, an agent used in the treatment of several cancers. Capecitabine is a prodrug that is enzymatically converted to 5-fluorouracil which inhibits the activity of thymidylate synthase necessary for the de novo DNA synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002132 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002132">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">capecitabine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002131"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T14:02:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002132</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00607</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of capecitabine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002133 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002133">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">capecitabine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002131"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T14:03:33Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002133</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00469</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of capecitabine-target interaction and of the biochemical or physiological responses to drug. Capecitabine  is used in the treatment of numerous cancers. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002134 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002134">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bupranolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001738"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T14:16:38Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002134</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00670</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of buoranolol - a non-selective adrenergic beta receptor blocker, used for the treatment of hypertension and other cardiovascular conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002135 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002135">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bupranolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002134"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T14:17:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002135</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of bupranolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002136 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002136">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bupranolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002134"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-10-29T14:17:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002136</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00670</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of buopranolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002146 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002146">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">direct thrombin inhibitor drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002151"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T11:47:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002146</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent the formation of blood clots by directly inhibiting thrombin. Thrombin is a serine protease involved in coagulation-related reactions. The drugs are further classified depending on how they interact with thrombin. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002147 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002147">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bivalirudin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002146"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T11:55:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002147</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of bivalirudin, a direct thrombin inhibitor. Bivalirudin binds to both the catalytic site and anion-binding exosite of thrombin and as classified as a bivalent inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002148 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002148">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bivalirudin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002147"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T11:55:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002148</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of bivalirudin, a bivalent direct thrombin inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002149 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002149">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bivalirudin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002147"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T11:56:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002149</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00277</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of bivalirudin-target interaction and of the biochemical or physiological responses to drug. The drug is a bivalent direct thrombin inhibitor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002150 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002150">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">antiplatelet drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001651"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T14:59:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002150</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of drugs that decrease platelet aggregation and inhibit blood clot formation. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002151 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002151">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">anticoagulant drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001651"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T15:04:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002151</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of drugs that prevent the coagulation of blood. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002152 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002152">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">thrombolytic drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001651"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T15:07:56Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002152</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of drugs that can dissolve blood clots. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002153 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002153">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bumetanide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T15:18:26Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002153</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of bumetanide - a blocker of luminal sodium-potassium-chloride symporter used for the treatment of heart failure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002154 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002154">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bumetanide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002153"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T15:22:40Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002154</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of bumetanide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002155 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002155">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bumetanide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002153"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T15:23:10Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002155</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00088</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of bumetanide-target interaction and of the biochemical or physiological responses to drug. The drug blocks the luminal sodium-potassium-chloride symporter in the thick ascending limb of the loop of Henle. Bumetanide is used in the treatment of heart failure.  Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002156 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002156">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bisoprolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001737"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T15:38:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002156</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of bisoprolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and several other conditions involving a faster than normal heart rate. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002157 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002157">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bisoprolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002156"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T15:39:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002157</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of bisoprolol. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002158 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002158">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bisoprolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002156"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T15:39:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002158</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00300</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of bisoprolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002159 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002159">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sensory organ drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T15:53:41Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002159</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used in the treatment of conditions affecting the sensory organs. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002160 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002160">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">betaxolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001737"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002159"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T15:58:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002160</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of betaxolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and glaucoma. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002161 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002161">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">betaxolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002160"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T15:58:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002161</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of betaxolol. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002162 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002162">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">betaxolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002160"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-02T15:59:06Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002162</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00299</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of betaxolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor used in the treatment of hypertension and glaucoma. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002163 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002163">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">moexipril drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001228"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-03T08:54:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002163</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of moexipril - an angiotensin converting enzyme (ACE) inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002164 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002164">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">moexipril pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001230"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002163"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-03T08:54:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002164</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00595</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of moexipril, an ACE inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002165 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002165">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">moexipril pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001231"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002163"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-03T08:59:40Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002165</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00151</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of moexipril-target interaction and of the biochemical or physiological responses to drug. The drug is an ACE inhibitor used for the treatment of hypertension and congestive heart failure. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002169 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002169">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">acebutolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001737"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-05T14:15:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002169</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of acebutolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension and arrhythmias. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002170 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002170">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">acebutolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002169"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-05T14:16:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002170</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of acebutolol. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002171 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002171">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">acebutolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002169"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-05T14:16:26Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002171</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00296</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of acebutolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002172 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002172">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">alendronate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001621"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-05T14:21:53Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002172</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of alendronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002173 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002173">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">alendronate pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001623"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002172"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-05T14:23:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002173</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of alendronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002174 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002174">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">alendronate pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001624"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002172"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-05T14:24:02Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002174</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00095</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of alendronate-target interaction and of the biochemical or physiological responses to drug. Alendronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002175 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002175">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pamidronate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001621"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-05T14:27:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002175</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of pamidronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002176 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002176">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pamidronate pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001623"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002175"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-05T14:28:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002176</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of pamidronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002177 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002177">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pamidronate pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001624"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002175"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-05T14:28:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002177</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00117</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of pamidronate-target interaction and of the biochemical or physiological responses to drug. Pamidronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002182 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002182">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">esomeprazole drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000918"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-05T15:16:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002182</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of esomeprazole, a proton pump inhibitor. It is administered for the treatment of acid-related disorders. The drug inhibits the hydrogen potassium ATPase in the parietal cells of the stomach. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002183 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002183">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">esomeprazole pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002182"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-05T15:17:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002183</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00612</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of esomeprazole, a compound in the class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002184 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002184">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">esomeprazole pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002182"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-05T15:18:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002184</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00225</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of esomeprazole-target interaction and of the biochemical or physiological responses to drug. Esomeprazole is a compound in the class of proton pump inhibitors used in the treatment of acid-related disorders. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002186 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002186">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">chlorothiazide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T08:33:21Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002186</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of chlorothiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002187 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002187">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">chlorothiazide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002186"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T08:34:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002187</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of chlorothiazide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002188 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002188">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">chlorothiazide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002186"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T08:34:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002188</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00078</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of chlorothiazide-target interaction and of the biochemical or physiological responses to drug. The drug reduces sodium reabsorption in the distal convoluted tubule of kidney nephron. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002189 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002189">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">buprenorphine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T08:43:27Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002189</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of buprenorphine, a semi-synthetic opioid and a mixed partial agonist opioid receptor modulator used to treat opioid addiction and to control moderate to acute pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002190 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002190">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">buprenorphine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002189"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T08:44:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002190</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of buprenorphine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002191 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002191">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">buprenorphine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002189"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T08:44:27Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002191</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00684</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of buprenorphine-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective, mixed agonist-antagonist opioid receptor modulator. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002192 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002192">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bupivacaine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002243"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T09:07:22Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002192</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of bupivacaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002193 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002193">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bupivacaine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002192"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T09:09:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002193</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of bupivacaine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002194 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002194">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bupivacaine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002192"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T09:09:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002194</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00393</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of bupivacaine-target interaction and of the biochemical or physiological responses to drug. It acts mainly as a voltage-gated sodium channel blocker. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002195 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002195">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bendroflumethiazide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T09:30:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002195</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of bendroflumethiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002196 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002196">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bendroflumethiazide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002195"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T09:30:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002196</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of bendroflumethiazide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002197 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002197">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bendroflumethiazide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002195"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T09:30:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002197</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00090</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of bendroflumethiazide-target interaction and of the biochemical or physiological responses to drug. The drug reduces sodium reabsorption in the distal convoluted tubule of kidney nephron. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002198 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002198">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">azithromycin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T09:40:37Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002198</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of azithromycin, an antibiotic that inhibits bacterial growth and used for the treatment of several bacterial infections and a number of sexually transmitted infections. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002199 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002199">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">azithromycin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002198"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T09:40:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002199</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination of azithromycin - an antibiotic that interferes with bacterial growth. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002200 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002200">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">azithromycin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002198"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T09:41:22Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002200</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00247</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of azithromycin-target interaction and of the biochemical or physiological responses to drug. The drug interferes with bacterial growth and is used for the treatment of several bacterial infections and a number of sexually transmitted infections. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002201 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002201">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">azathioprine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002369"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T09:50:24Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002201</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of azathioprine, an immunosupressive drug used in organ transplantation and autoimmune diseases. It is a prodrug for mercaptopurine, thus inhibiting DNA synthesis.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002202 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002202">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">azathioprine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002201"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T09:50:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002202</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of azathioprine, a meracptopurine prodrug. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002203 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002203">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">azathioprine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002201"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-09T09:51:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002203</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00427</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of azathioprine-target interaction and of the biochemical or physiological responses to drug. It is an immunosupressive drug that inhibits DNA synthesis. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002221 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002221">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">aprotinin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001652"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-12T09:49:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002221</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of aprotinin, an antifibrinolytic inhibitor of trypsin and other serine proteases, used to reduce bleeding during surgery. Once withdrawn from the market, it has been reintroduced. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002222 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002222">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">aprotinin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002221"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-12T09:49:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002222</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of aprotinin. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002223 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002223">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">aprotinin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002221"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-12T09:49:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002223</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00288</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of aprotinin-target interaction and of the biochemical or physiological responses to drug. Aprotinin is a serine protease inhibitor of trypsin, chymotrypsin and others. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002224 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002224">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">arbekacin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000996"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-12T10:06:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002224</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of arbekacin, an antibiotic used for the treatment of infections caused by multi-resistant bacteria. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002225 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002225">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">arbekacin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002224"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-12T10:07:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002225</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of arbekacin. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002226 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002226">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">arbekacin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002224"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-12T10:08:10Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002226</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00713</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of arbekacin-target interaction and of the biochemical or physiological responses to drug. Arbekacin inhibits protein synthesis by irreversibly binding to bacterial 30S ribosomal subunit. The drug is used for the treatment of infections caused by multi-resistant bacteria. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002227 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002227">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">argatrobran drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002146"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-12T10:29:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002227</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of argatroban, a direct thrombin inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002228 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002228">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">argatrobran pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002227"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-12T10:30:50Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002228</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of argatroban, a direct thrombin inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002229 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002229">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">argatroban pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002227"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-12T10:31:14Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002229</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00276</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of argatroban-target interaction and of the biochemical or physiological responses to drug. The drug is a direct thrombin inhibitor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002230 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002230">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">atenolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001737"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-12T10:40:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002230</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of atenotolol, a selective beta adrenergic type 1 receptor antagonist used in the treatment of hypertension. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002231 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002231">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">atenolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002230"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-12T10:41:27Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002231</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of atenolol. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002232 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002232">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">atenolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002230"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-12T10:41:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002232</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00298</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of atenolol-target interaction and of the biochemical or physiological responses to drug. The drug is a selective antagonist of beta adrenergic type 1 receptor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002237 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002237">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">penbutolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001738"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-17T09:12:59Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002237</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of penbutolol - a non-selective adrenergic beta receptor blocker, used in the treatment of high blood pressure. Penbutolol is a sympathomimetic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002238 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002238">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">penbutolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002237"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-17T09:13:41Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002238</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of penbutolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002239 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002239">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">penbutolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002237"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-17T09:14:09Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002239</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00305</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of penbutolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002240 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002240">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">oxeprenolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001738"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-17T09:17:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002240</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of oxeprenolol - a non-selective adrenergic beta receptor blocker, used for the treatment of angina, high blood pressure and abnormal heart rhythms. The drug has some intrinsic sympathomimetic properties. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002241 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002241">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">oxeprenolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002240"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-17T09:22:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002241</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of oxeprenolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002242 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002242">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">oxeprenolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002240"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-17T09:22:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002242</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00304</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of oxeprenolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002243 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002243">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">anesthetic drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000923"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-18T15:14:45Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002243</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used to cause reversible loss of sensation and generally administered to facilitate surgery.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002244 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002244">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">prilocaine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002243"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-18T15:30:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002244</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of prilocaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002245 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002245">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">prilocaine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002244"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-18T15:30:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002245</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of prilocaine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002246 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002246">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">prilocaine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002244"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-18T15:31:22Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002246</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00401</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of prilocaine-target interaction and of the biochemical or physiological responses to drug. The drug exerts its effects by blocking the voltage-gated sodium channels. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002247 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002247">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ropivacaine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002243"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-18T15:37:03Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002247</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of ropivacaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002248 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002248">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ropivacaine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002247"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-18T15:37:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002248</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of ropivacaine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002249 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002249">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ropivacaine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002247"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-18T15:38:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002249</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00404</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ropivacaine-target interaction and of the biochemical or physiological responses to drug. The drug exerts its effects by blocking the voltage-gated sodium channels. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002250 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002250">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">torasemide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T09:50:53Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002250</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of torasemide, a diuretic drug mainly used in the management of edema associated with congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">torsemide drug pathway</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002251 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002251">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">torasemide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002250"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T09:52:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002251</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of torasemide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">torsemide pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002252 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002252">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">torasemide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002250"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T09:52:31Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002252</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00118</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of torasemide-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">torsemide pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002256 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002256">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">reteplase drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002152"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T10:47:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002256</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of reteplase - one of several recombinant tissue plasminogen activators. Plasminogen is a key player in the fibrinolytic cascade pathway of blood clots breakdown. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002257 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002257">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">reteplase pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002256"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T10:47:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002257</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of reteplase, one of several recombinant tissue plasminogen activators. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002258 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002258">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">reteplase pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002256"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T10:47:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002258</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00285</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of reteplase-target interaction and of the biochemical or physiological responses to drug. Reteplase is one of several recombinant tissue plasminogen activators. Reteplase is used to treat heart attack. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002259 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002259">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nadolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001738"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T10:56:45Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002259</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of nadolol - a non-selective adrenergic beta receptor blocker, used in the treatment of high blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002260 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002260">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nadolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002259"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T10:57:38Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002260</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of nadolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002261 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002261">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">nadolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002259"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T10:58:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002261</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00303</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of nadolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002262 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002262">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pindolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001738"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T11:03:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002262</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of pindolol - a non-selective adrenergic beta receptor blocker, used in the treatment of high blood pressure. Pindolol is a sympathomimetic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002263 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002263">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pindolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002262"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T11:08:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002263</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of pindolol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002264 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002264">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pindolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002262"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T11:08:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002264</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00306</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of pindolol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002265 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002265">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">teniposide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T11:41:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002265</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of teniposide, a drug used to treat childhood leukemia. The drug inhibits DNA synthesis. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002266 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002266">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">teniposide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002265"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T11:46:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002266</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00602</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of teniposide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002267 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002267">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">teniposide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002265"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-20T11:47:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002267</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00443</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of teniposide-target interactions and of the biochemical or physiological responses to drug. The drug is used in the treatment of certain cancers and its mode of action is believed to be inhibition of DNA synthesis. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002268 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002268">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">zoledronate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001621"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T08:18:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002268</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of zoledronate - a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002269 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002269">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">zoledronate pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002268"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T08:20:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002269</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of zoledronate, a nitrogenous bisphosphonate drug. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002270 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002270">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">zoledronate pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002268"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T08:21:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002270</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00107</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of zoledronate-target interaction and of the biochemical or physiological responses to drug. Zoledronate is a nitrogenous bisphosphonate drug used to treat bone diseases. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002271 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002271">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">eplerenone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T08:31:02Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002271</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of eplrenone, a drug used as an adjunct in the management of chronic heart failure. enetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002272 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002272">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">eplerenone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002271"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T08:31:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002272</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of eplerenone. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002273 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002273">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">eplerenone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002271"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T08:31:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002273</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00135</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of eplerenone-target interaction and of the biochemical or physiological responses to drug. Eplerenone is an antagonist of the mineralocorticoid receptor and indicated for the reduction of cardiovascular death risk in people with heart failure.  Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002278 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002278">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fenoprofen drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T10:30:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002278</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of fenoprofen, a non-steroidal anti-inflammatory drug used  in the treatment of rheumatoid arthritis and mild pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002279 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002279">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fenoprofen pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002278"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T10:44:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002279</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of fenoprofen. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002280 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002280">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fenoprofen pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002278"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T10:44:26Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002280</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00696</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of fenoprofen-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of rheumatoid arthritis and mild pain.  Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002281 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002281">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">various drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T10:58:52Z</oboInOwl:creation_date>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">One of the subgroups of the Therapeutic Chemical  Classification System developed by WHO for grouping drugs acting as antidotes, chelators, detoxifying agents, and others. The pharmacokinetics and pharmacodynamics of such agents. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002281</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002282 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002282">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">naloxone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002281"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T11:03:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002282</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of naloxone, a medication used to reverse the effects opioids overdose. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002283 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002283">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">naloxone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002282"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T11:04:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002283</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of naloxone. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002284 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002284">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">naloxone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002282"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T11:05:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002284</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00688</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of naloxone-target interaction and of the biochemical or physiological responses to drug. Naloxone is a mu-opioid receptor competitive antagonist. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002286 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002286">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cilostazol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002150"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T14:28:24Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002286</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of cilostazol, a platelet aggregation inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002287 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002287">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cilostazol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002286"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T14:29:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002287</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of cilostazol, a platelet aggregation inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002288 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002288">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cilostazol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002286"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-23T14:30:02Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002288</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00263</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of cilostazol-interaction and of the biochemical or physiological responses to drug. The drug is a selective inhibitor of phosphodiesterase type 3. The increase in cyclic AMP (cAMP) and subsequent increase in active protein kinase A (PKA) leads to inhibition of platelet aggregation. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002295 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002295">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">antiepileptic drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000923"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-24T09:53:06Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002295</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used in the treatment of epilepsy or seizure. Some can also act as mood stabilizers.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002296 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002296">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fosphenytoin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002295"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-24T09:56:33Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002296</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of fosphenytoin, a drug used in the treatment of acute convulsive epileptic seizure. Fosphenytoin is a water-soluble phenytoin prodrug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002297 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002297">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fosphenytoin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002296"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-24T09:57:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002297</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00618</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of fosphenytoin, a prodrug used for the treatment of epilepsy. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002298 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002298">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fosphenytoin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002296"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-11-24T09:57:45Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002298</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00326</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of fosphenytoin-target interaction and of the biochemical or physiological responses to drug. Fosphenytoin is a water-soluble phenytoin prodrug used for the treatment of epilepsy. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002303 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002303">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">indometacin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001546"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-02T14:30:20Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002303</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of indometacin, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and is used in the treatment of inflammation and pain and to reduce fever. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002304 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002304">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">indometacin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002303"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-02T14:35:10Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002304</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of indometacin. The drug is used in the treatment of pain and inflammation and to reduce fever. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002305 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002305">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">indometacin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002303"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-02T14:35:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002305</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00104</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of indometacin-target interaction and of the biochemical or physiological responses to drug. Indometcin is an inhibitor of cyclooxygenase enzymes used in the treatment of pain and inflammation and to reduce fever. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002307 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002307">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levobunolol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001738"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002159"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-03T09:47:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002307</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of levobunolol, a non-selective beta adrenergic receptor antagonist used in the treatment of glaucoma. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002308 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002308">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levobunolol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002307"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-03T09:49:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002308</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of levobunolol. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002309 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002309">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levobunolol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002307"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-03T09:49:46Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002309</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00666</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of levobunolol-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective antagonist of beta adrenergic used in the treatment of glaucoma. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002310 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002310">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">doxepin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002113"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-03T10:07:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002310</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of desipramine, an antidepressant used in the treatment of depression, anxiety disorders, insomnia. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002311 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002311">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">doxepin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002310"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-03T10:07:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002311</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00641</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of doxepin. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002312 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002312">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">doxepin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002310"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-03T10:08:21Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002312</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of doxepin-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of depression, anxiety disorders, insomnia. Its effects result from inhibition of serotonin and norepinephrine neurotransmitter reuptake. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002313 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002313">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">indometacin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-04T08:50:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002313</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of indometacin, a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes. It is commonly used to reduce fever, pain and swelling in wide range of conditions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">indomethacin drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002314 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002314">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">indometacin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002313"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-04T08:50:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002314</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of indometacin. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">indomethacin pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002315 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002315">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">indometacin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002313"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-04T08:51:14Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002315</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00104</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of indometacin-target interaction and of the biochemical or physiological responses to drug. Indometacin is an inhibitor of cyclooxygenase enzymes and commonly used to reduce fever, pain and swelling in a wide range of conditions. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">indomethacin pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002316 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002316">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">psychostimulant drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000923"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T08:26:41Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002316</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of psychoactive drugs that can induce an improvement in the  mental or physical activity. While such drugs are used as prescription medicine they can also be abused and some substances in this category are illicit.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002317 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002317">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">caffeine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002316"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T08:35:37Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002317</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of caffeine, a psychostimulant of the methylxanthine class. It can confer some protective effects against some conditions. It is largely considered safe but the pure powdered caffeine, available as dietary supplement, can be lethal in higher amounts. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002318 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002318">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">caffeine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002317"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T08:36:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002318</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00028</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of caffeine, a widely used stimulant of the central nervous system. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002319 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002319">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">caffeine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002317"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T08:36:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002319</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of caffeine-target interaction and of the biochemical or physiological responses to drug. Caffeine is an antagonist of adenosine receptors of all types. As such, it stimulates vasomotor and respiratory centers and also promotes neurotransmitter release. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002320 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002320">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">trichlormethiazide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T08:58:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002320</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of trichlormethiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002321 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002321">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">trichlormethiazide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002320"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T08:58:51Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002321</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of trichlormethiazide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002322 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002322">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">trichlormethiazide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002320"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T08:59:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002322</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00121</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of trichlormethiazide-target interaction and of the biochemical or physiological responses to drug. The drug is thought to block reabsorption of chloride and possibly sodium in the ascending loop of Henle. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002325 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002325">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vitamin K antagonist drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002151"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T09:44:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002325</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of drugs that prevent the coagulation of blood acting as vitamin K inhibitors . Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002326 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002326">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">heparin group drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002151"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T09:52:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002326</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of heparin group drugs that reduce or prevent the formation of blood clots by activating the antithrombin III (AT) thrombin inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002327 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002327">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">heparin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002326"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T09:55:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002327</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of heparin, a naturally occurring anticoagulant produced by basophils and mast cells. Heparin, and its low molecular weight derivative, bind to and activates the thrombin enzyme inhibitor antithrombin III. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002328 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002328">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">heparin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002327"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T09:56:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002328</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of heparin. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002329 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002329">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">heparin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002327"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T09:56:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002329</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00274</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of heparin-target interaction and of the biochemical or physiological responses to drug. Heparin is a naturally occurring anticoagulant that binds to and activates the thrombin inhibitor antithrombin III (AT). Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002330 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002330">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">enoxaparin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002326"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T09:57:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002330</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of enoxaparin, a low molecular weight heparin derivative. The drug is an anticoagulant that activates the thrombin inhibitor antithrombin III (AT). Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002331 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002331">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">enoxaparin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002330"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T09:58:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002331</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of enoxaparin. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002332 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002332">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">enoxaparin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002330"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-07T09:58:21Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002332</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00272</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of enoxaparin-target interaction and of the biochemical or physiological responses to drug. Enoxaparin is a low molecular weight heparin derivative anticoagulant that binds to and activates the thrombin inhibitor antithrombin III (AT). Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002333 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002333">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">phenytoin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002295"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002336"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-08T14:31:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002333</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of fosphenytoin, an anti-seizure medication also used for certain heart arrhythmias. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002334 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002334">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">phenytoin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002333"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-08T14:31:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002334</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of phenytoin. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002335 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002335">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">phenytoin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002333"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-08T14:32:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002335</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00327</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of phenytoin-target interaction and of the biochemical or physiological responses to drug. The drug is used as an anti-seizure medication and also for certain heart arrhythmias. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002336 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002336">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">antiarrhythmic drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000920"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-08T14:42:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002336</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of drugs used in the treatment of arrythmias.  Some beta receptor and channel blockers may also act as antiarrhythmic agents. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002337 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002337">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mexiletine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002336"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-08T14:55:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002337</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of mexiletine, a drug used in the treatment of cardiac arrhythmias. Mexiletine is a non-selective voltage-gated sodium channel blocker of the Class IB antiarrhythimc drugs. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002338 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002338">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mexiletine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002337"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-08T14:56:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002338</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of mexiletine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002339 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002339">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mexiletine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002337"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-08T14:57:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002339</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00329</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of mexiletine-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective voltage-gated sodium channel blocker  antiarrhythmic agent. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002344 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002344">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">etoposide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-09T15:29:06Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002344</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of etoposide, a cytotoxic anticancer drug in the topoisomerase inhibitor class. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002345 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002345">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">etoposide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002344"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-09T15:30:50Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002345</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00601</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of etoposide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002346 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002346">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">etoposide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002344"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-09T15:31:33Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002346</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00442</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of etoposide-target interactions and of the biochemical or physiological responses to drug. Etoposide is a cytotoxic anticancer drug in the topoisomerase inhibitor class. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002348 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002348">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lornoxicam drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001546"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-15T08:39:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002348</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of lornoxicam, a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic properties Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002349 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002349">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lornoxicam pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002348"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-15T08:40:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002349</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of lornoxicam. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002350 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002350">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lornoxicam pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002348"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-15T08:40:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002350</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00700</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of lornoxicam-target interaction and of the biochemical or physiological responses to drug. The drug is used to relieve various types of pain. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002351 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002351">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">trastuzumab drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002370"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-15T09:22:35Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002351</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of trastuzumab, a monoclonal antibody that interferes with the epidermal growth factor receptor 2, overexpressed in certain cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002352 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002352">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">trastuzumab pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002351"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-15T09:23:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002352</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of trastuzumab. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002353 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002353">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">trastuzumab pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002351"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-15T09:23:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002353</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00476</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of trastuzumab-target interaction and of the biochemical or physiological responses to drug. The drug interferes with the epidermal growth factor receptor 2, overexpressed in certain cancer types. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002354 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002354">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">antiparasitic drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-15T09:52:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002354</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used as antiparasitic agents. Genetic variations can result in changes in drug availability.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002355 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002355">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">artemether drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002354"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-15T09:56:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002355</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of artemether, an antimalarial agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002356 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002356">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">artemether pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002355"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-15T09:56:40Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002356</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00651</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of artemether. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002357 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002357">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">artemether pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002355"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-15T09:57:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002357</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of artemether-target interactions and of the biochemical or physiological responses to drug. Artemether is used to treat malaria.  Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002361 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002361">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">remifentanil drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002243"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-17T08:00:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002361</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of remifentanil, a synthetic opioid analgesic used in general anesthesia.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002362 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002362">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">remifentanil pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002361"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-17T08:01:50Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002362</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of remifentanil. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002363 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002363">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">remifentanil pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002361"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-17T08:02:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002363</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00416</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of remifentanil-target interaction and of the biochemical or physiological responses to drug. The drug is a synthetic opioid analgesic used in general anesthesia. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002367 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002367">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">antineoplastic drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000919"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-17T09:05:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002367</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of drugs used in the treatment of various cancers. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002368 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002368">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">immunostimulant drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000919"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-17T09:05:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002368</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of drugs used as immunostimulants. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002369 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002369">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">immunosuppressant drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000919"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-17T09:06:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002369</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of drugs used as immunosupressants. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002370 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002370">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">monoclonal antibody drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-17T09:16:14Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002370</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of monoclonal antibodies used in the treatment of various types of cancer.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002371 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002371">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cetuximab drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002370"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-17T09:38:50Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002371</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of cetuximab, a chimeric (mouse/human) monoclonal antibody that interferes with the epidermal growth factor receptor (EGFR) and used for the treatment of certain cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002372 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002372">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cetuximab pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002371"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-17T09:39:25Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002372</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of cetuximab. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002373 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002373">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cetuximab pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002371"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-17T09:39:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002373</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00474</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of cetuxiumab-target interaction and of the biochemical or physiological responses to drug. The drug interferes with the epidermal growth factor receptor (EGFR) and is used for the treatment of certain cancer types. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002374 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002374">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">panitumumab drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002370"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-17T09:45:33Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002374</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of panitumumab, a human monoclonal antibody that interferes with the epidermal growth factor receptor (EGFR) and used for the treatment of certain cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002375 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002375">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">panitumumab pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002374"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-17T09:46:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002375</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of panitumumab. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002376 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002376">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">panitumumab pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002374"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-17T09:47:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002376</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00475</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of panitumumab-target interaction and of the biochemical or physiological responses to drug. The drug interferes with the epidermal growth factor receptor (EGFR) and is used for the treatment of certain cancer types. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002377 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002377">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hydroflumethiazide drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002121"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-21T08:49:37Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002377</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of hydroflumethiazide, a drug used in the treatment of high blood pressure.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002378 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002378">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hydroflumethiazide pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002377"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-21T08:51:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002378</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of hydroflumethiazide. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002379 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002379">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hydroflumethiazide pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002377"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-21T08:52:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002379</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00108</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of hydroflumethiazide-target interaction and of the biochemical or physiological responses to drug. The drug reduces sodium reabsorption in the distal convoluted tubule of kidney nephron. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002382 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002382">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dobutamine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000920"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-21T09:41:20Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002382</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of dobutamine, a drug used in the treatment of heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002383 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002383">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dobutamine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002382"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-21T09:41:51Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002383</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of dobutamine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002384 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002384">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dobutamine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002382"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-21T09:42:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002384</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00662</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of dobutamine-target interaction and of the biochemical or physiological responses to drug. The drug is an agonist of beta 1 adrenergic receptor used in the treatment of heart failure. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002385 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002385">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">clomipramine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002113"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-21T10:00:09Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002385</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of clomipramine, an antidepressant used in the treatment of obsessive compulsive disorder, panic disorder, major depressive disorder. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002386 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002386">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">clomipramine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002385"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-21T10:00:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002386</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00639</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of clomipramine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002387 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002387">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">clomipramine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002385"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-21T10:01:06Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002387</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of clomipramine-target interaction and of the biochemical or physiological responses to drug. The drug is categorized as a non-selective monoamine reuptake inhibitor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002389 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002389">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">felbamate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002295"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-21T15:20:39Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002389</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of felbamate - an anticonvulsant used in the treatment of epilepsy. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002390 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002390">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">felbamate pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002389"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-21T15:22:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002390</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00633</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of felbamate. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002391 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002391">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">felbamate pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002389"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-21T15:22:53Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002391</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of felbamate-target interaction and of the biochemical or physiological responses to drug. It is used for the treatment of severe epilepsy due to its adverse effects, particularly hepatic failure. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002392 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002392">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tioguanine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-29T12:59:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002392</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of tioguanine, a drug used to treat several leukemia types, ulcerative colitis and some autoimmune diseases. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">thioguanine drug pathway</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002393 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002393">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tioguanine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002392"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-29T12:59:53Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002393</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00647</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of tioguanine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">thioguanine pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002394 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002394">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tioguanine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002392"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015-12-29T13:00:41Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002394</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00430</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of teniposide-target interactions and of the biochemical or physiological responses to drug. The drug is used in the treatment of several leukemia types, ulcerative colitis and some autoimmune diseases. Derivatives of tioguanine exert several cytotoxic effects. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">thioguanine pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002434 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002434">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">other antithrombotic drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001651"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-25T14:43:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002434</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent the formation of blood clots.  They are further classified depending on the blood clotting processes they affect. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002435 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002435">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fondaparinux drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002434"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-25T14:48:41Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002435</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of fondaparinux, a synthetic pentasaccharide factor Xa inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002436 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002436">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fondaparinux pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002435"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-25T14:50:39Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002436</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of fondaparinux. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002437 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002437">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fondaparinux pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002435"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-25T14:51:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002437</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00273</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of fondaparinux-target interaction and of the biochemical or physiological responses to drug. Fondaparinux is a synthetic pentasaccharide factor Xa inhibitor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002440 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002440">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levobupivacaine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002243"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-25T15:24:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002440</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of levobupivacaine, a drug used as a local anesthetic. It is the S-enantiomer of bupivacaine compared to which, it has a longer duration of action and is associated with less vasodilation. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002441 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002441">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levobupivacaine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002440"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-25T15:25:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002441</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of levobupivacaine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002442 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002442">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levobupivacaine phgarmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002440"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-25T15:25:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002442</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00397</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of levobupivacaine-target interaction and of the biochemical or physiological responses to drug.  It is the S-enantiomer of bupivacaine compared to which, it has a longer duration of action and is associated with less vasodilation. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002443 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002443">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">opioid drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001546"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-26T09:21:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002443</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used to alleviate pain and which act on the nervous system in a way similar to opiate. They can be natural opiates, like morphine or codeine, endogenous opioid peptide, like endorphins, semi- or fully synthetic opioids, or drugs that chemically are not of the opioid class but act as agonists of opioid receptors. Others can act as antagonists or mixed agonists/antagonists. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002444 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002444">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">oxycodone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-26T09:38:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002444</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of oxycodone, a semi-synthetic opioid and a narcotic analgesic indicated for relief of moderate to severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002445 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002445">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">oxycodone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002444"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-26T09:39:26Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002445</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of oxycodone. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002446 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002446">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">oxycodone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002444"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-26T09:39:50Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002446</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00409</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of oxycodone-target interaction and of the biochemical or physiological responses to drug. It is thought to act on different opioid receptors in different situations. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002447 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002447">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hydromorphone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-26T09:49:25Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002447</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of hydromorphone, a derivative of the morphine family and a potent analgesic opioid drug and a narcotic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002448 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002448">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hydromorphone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002447"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-26T09:49:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002448</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of hydromorphone. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002449 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002449">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hydromorphone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002447"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-26T09:50:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002449</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00410</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of hydromorphone-target interaction and of the biochemical or physiological responses to drug. The drug is a mu-receptor agonist whose major effects are on the central nervous system and gastrointestinal tract. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002450 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002450">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hydrocodone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-26T10:01:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002450</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of hydrocodone, a narcotic analgesic synthesized from codeine and used for relief of moderate to severe pain. It is also used as an antitussive to treat cough. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002451 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002451">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hydrocodone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002450"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-26T10:01:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002451</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of hydrocodone. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002452 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002452">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hydrocodone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002450"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-26T10:02:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002452</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00411</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of hydrocodone-target interaction and of the biochemical or physiological responses to drug. It primarily acts on the mu-opioid receptor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002453 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002453">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">oxymorphone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-26T10:08:10Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002453</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of oxymorphone, a semi-synthetic opioid analgesic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002454 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002454">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">oxymorphone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002453"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-26T10:08:39Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002454</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of oxymorphone. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002455 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002455">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">oxymorphone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002453"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-26T10:09:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002455</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00412</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of oxymorphone-target interaction and of the biochemical or physiological responses to drug. It acts on the mu-opioid receptor and to a lesser extent, the delta receptor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002456 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002456">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">salicylic acid drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001546"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002150"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002159"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002459"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-27T10:17:10Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002456</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of salicylic acid derived from salicin, an anti-inflammatory agent produced in willow bark. It is best known for its use in anti-acne products. As a drug, it is used in the treatment of pain and inflammation and to reduce fever. Its salts and esters are known as salicylates. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002457 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002457">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">salicylic acid pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002456"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-27T10:18:52Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002457</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of salicylic acid. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002458 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002458">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">salicylic acid pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002456"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-27T10:19:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002458</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00709</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of salicylic acid-target interaction and of the biochemical or physiological responses to drug. Salicylic acid is used in the treatment of pain and inflammation and to reduce fever. Salts and esters of salicylic acid are known as salicylates. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002459 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002459">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dermatological drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000754"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-27T10:35:16Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002459</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used for the treatment of conditions related to skin, hair and nails. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002460 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002460">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sodium salicylate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001546"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-27T10:45:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002460</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of sodium salicylate, a sodium salt of salicylic acid, used as an analgesic and antipyretic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002461 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002461">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sodium salicylate pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002460"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-27T10:45:51Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002461</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of sodium salicylate. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002462 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002462">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sodium salicylate pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002460"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-27T10:46:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002462</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00708</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of salicylic acid-target interaction and of the biochemical or physiological responses to drug. Sodium salicylate is used as an analgesic and antipyretic. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002463 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002463">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">carbamazepine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002295"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-29T08:38:19Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002463</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of carbamazepine, a drug used in the treatment of epilepsy and neuropathic pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002464 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002464">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">carbamazepine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002463"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-29T08:40:30Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002464</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00634</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of carbamazepine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002465 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002465">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">carbamazepine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002463"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-29T08:41:33Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002465</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of carbamazepine-target interaction and of the biochemical or physiological responses to drug. Carbamazepine is used in the treatment of epilepsy and neuropathic pain. The drug stabilizes the inactivated state of voltage-gated sodium channels and can also act as a GABA receptor agonist. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002468 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002468">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">felodipine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001894"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-29T09:37:07Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002468</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of felodipine, a calcium channel blocker used for the treatment of high blood pressure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002469 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002469">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">felodipine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002468"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-29T09:37:50Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002469</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00619</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of felodipine. The drug is a calcium channel blocker used in the treatment of high blood pressure.  Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002470 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002470">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">felodipine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002468"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-01-29T09:38:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002470</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of felodipine-target interaction and of the biochemical or physiological responses to drug. The drug is a calcium channel blocker used for the treatment of high blood pressure.  Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002472 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002472">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">other antidepressant drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002114"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-02T11:56:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002472</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of compounds used to treat various forms of depression.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002473 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002473">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">venlafaxine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002472"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-02T11:58:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002473</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of venlafaxine, a drug used in the treatment of major depressive, anxiety and panic disorders. The drug inhibits the reuptake of key neurotransmitters such as serotonin, epinephrine and dopamine. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002474 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002474">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">venlafaxine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002473"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-02T11:58:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002474</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00636</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of venlafaxine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002475 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002475">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">venlafaxine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002473"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-02T11:59:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002475</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of venlafaxiine-target interaction and of the biochemical or physiological responses to drug. The drug inhibits the reuptake of key neurotransmitters such as serotonin, epinephrine and dopamine. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002476 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002476">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">rosiglitazone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000723"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-02T12:09:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002476</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of rosiglitazone, an anti-diabetic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug. In several countries the drug was withdrawn from the market due to its side effects.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002477 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002477">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">rosiglitazone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002476"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-02T12:10:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002477</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00653</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of rosiglitazone, an anti-diabetic drug. Genetic variations can result in changes in the availability of the drug. In several countries the drug was withdrawn from the market due to its side effects.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002478 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002478">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">rosiglitazone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002476"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-02T12:11:39Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002478</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of rosiglitazone-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.  In several countries rosiglitazone was withdrawn from the market due to its side effects.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002482 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002482">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">chloroprocaine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002243"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-04T14:08:03Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002482</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of chloroprocaine, a drug used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002483 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002483">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">chloroprocaine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002482"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-04T14:08:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002483</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of chloroprocaine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002484 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002484">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">chloroprocaine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002482"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-04T14:09:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002484</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00394</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of chloroprocaine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002485 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002485">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">prednisolone drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000921"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000924"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001203"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002159"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002459"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-04T14:20:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002485</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of prednisolone - a synthetic glucocorticoid used to treat a wide range of inflammatory and autoimmune conditions, and also allergic reactions. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002486 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002486">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">prednisolone pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002485"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-04T14:21:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002486</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00632</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of prednisolone, a synthetic glucocorticoid. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002487 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002487">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">prednisolone pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002485"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-04T14:21:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002487</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00441</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of prednisolone-target interaction and of the biochemical or physiological responses to drug. used to treat a wide range of inflammatory and autoimmune conditions, and also allergic reactions. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002492 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002492">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">phenindione drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002325"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-09T11:48:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002492</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of phenindione. The drug is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002493 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002493">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">phenindione pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002492"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-09T11:49:26Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002493</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of phenindione.  Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002494 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002494">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">phenindione pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002492"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-09T11:49:53Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002494</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00655</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of phenindione-target interaction and of the biochemical or physiological responses to drug. Phenindione is used as anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002495 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002495">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dicoumarol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002325"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-09T11:55:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002495</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of dicoumarol. Dicoumarol is a naturally occurring anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dicumarol drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002496 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002496">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dicoumarol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002495"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-09T11:55:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002496</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of dicoumarol.  Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dicumarol pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002497 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002497">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dicoumarol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002495"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-09T11:56:13Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002497</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00270</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00656</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of dicoumarol-target interaction and of the biochemical or physiological responses to drug.  Dicoumarol is a naturally occurring anticoagulant that antagonizes the vitamin K dependent clotting pathway. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dicumarol pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002498 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002498">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">adrenergic beta receptor agonist drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000920"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-10T10:19:22Z</oboInOwl:creation_date>
        <oboInOwl:hasAlternativeId rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001736</oboInOwl:hasAlternativeId>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002498</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of adrenergic beta receptors agonists. The drugs can be either selective or non-selective. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002499 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002499">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">adrenergic beta receptor selective agonist drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002498"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-10T10:22:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002499</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of selective adrenergic beta receptors agonists. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002500 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002500">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">adrenergic beta receptor non-selective agonist drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002498"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-10T10:23:09Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002500</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of non-selective adrenergic beta receptors agonists. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002501 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002501">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">isoprenaline drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002500"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-10T10:36:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002501</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of isoprenaline, a non-selective beta adrenergic agonist used for the treatment of heart block and slow heart rate. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002502 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002502">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">isoprenaline pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002501"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-10T10:39:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002502</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of isoprenaline. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002503 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002503">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">isoprenaline pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002501"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-10T10:40:01Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002503</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00663</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of isoprenaline-target interaction and of the biochemical or physiological responses to drug. The drug is a non-selective beta adrenergic agonist used for the treatment of heart block and slow heart rate.  Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002507 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002507">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mycophenolic acid drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002369"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-12T08:51:42Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002507</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of mycophenolic acid - an immunosuppressant drug used to prevent rejection in organ transplantation. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002508 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002508">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mycophenolic acid pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002507"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-12T08:52:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002508</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00652</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of mycophenolic acid. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002509 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002509">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">mycophenolic acid pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002507"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-12T08:53:23Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002509</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of mycophenolic acid-target interaction and of the biochemical or physiological responses to drug. Mycophenolic acid is used as an immunosuppressant to prevent organ rejection in transplantation. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002514 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002514">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tiaprofenic acid drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-16T12:29:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002514</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of tiaprofenic acid, a non-steroidal anti-inflammatory drug used  to treat pain, especially arthritic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002515 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002515">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tiaprofenic acid pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002514"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-16T12:32:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002515</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002516 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002516">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">tiaprofenic acid pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002514"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-16T12:34:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002516</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00705</oboInOwl:hasRelatedSynonym>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002522 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002522">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">flurbiprofen drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001170"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002159"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-22T15:27:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002522</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of flurbiprofen, a non-steroidal anti-inflammatory drug used  in the treatment of arthritis and dental pain and also as a pre-operative solution. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002523 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002523">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">flurbiprofen pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002522"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-22T15:30:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002523</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of flurbiprofen. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002524 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002524">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">flurbiprofen pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002522"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-22T15:30:45Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002524</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00697</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of flurbiprofen-target interaction and of the biochemical or physiological responses to drug. The drug is used in the treatment of arthritis and dental pain and also as a pre-operative solution.  Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002525 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002525">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ethylmorphine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000924"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002159"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-22T15:38:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002525</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of ethylmorphine, an opiate narcotic analgesic mostly used to treat dry cough and as an ophtalmologic agent. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002526 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002526">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ethylmorphine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002525"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-22T15:43:57Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002526</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of ethylmorphine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002527 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002527">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ethylmorphine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002525"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-22T15:44:28Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002527</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00681</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of ethylmorphine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002528 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002528">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">magnesium salicylate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001546"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-23T15:51:27Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002528</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of magnesium salicylate, used as an analgesic and antipyretic drug. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002529 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002529">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">magnesium salicylate pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002528"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-23T15:55:32Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002529</oboInOwl:id>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002530 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002530">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">magnesium salicylate pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002528"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-23T15:56:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002530</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00698</oboInOwl:hasRelatedSynonym>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002533 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002533">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cocaine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002243"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-24T10:09:11Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002533</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of cocaine, a drug of few medical uses, mostly as a local anesthetic during surgery. Cocaine is highly addictive due to its effects on the reward system in the brain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002534 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002534">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cocaine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002533"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-24T10:10:10Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002534</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of cocaine, a drug of limited medical uses. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002535 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002535">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">cocaine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002533"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-24T10:10:35Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002535</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00395</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of cocaine-target interaction and of the biochemical or physiological responses to drug. Cocaine has few medical uses, mostly as local anesthetic during surgery. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002536 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002536">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lidocaine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002243"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002336"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-24T10:24:47Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002536</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of lidocaine, an important class 1b antiarrhythmic drug also used as a local anesthetic. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002537 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002537">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lidocaine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002536"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-24T10:26:31Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002537</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00620</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of lidocaine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002538 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002538">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">lidocaine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002536"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-24T10:26:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002538</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00328</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00398</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of lidocaine-target interaction and of the biochemical or physiological responses to drug. Lidocaine is an important class 1b antiarrhythmic drug also used as a local anesthetic. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002539 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002539">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">oxybuprocaine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002159"/>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002243"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-25T08:41:40Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002539</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of oxybuprocaine, a drug used as a local anesthetic, particularly in ophtalmology and otolaryngology. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002540 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002540">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">oxybuprocaine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002539"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-25T08:42:31Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002540</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of oxybuprocaine. Genetic variations can result in changes in the availability of the drug.  Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002541 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002541">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">oxybuprocaine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002539"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-25T08:43:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002541</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00400</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of oxybuprocaine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002542 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002542">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dihydromorphine drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-25T08:55:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002542</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of dihydromorphine, a semi-synthetic opioid used for the management of moderate to severe pain. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002543 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002543">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dihydromorphine pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002542"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-25T08:56:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002543</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of dihydrolmorphine. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002544 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002544">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dihydromorphine pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002542"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-02-25T08:56:41Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002544</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00689</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of dihydromorphine-target interaction and of the biochemical or physiological responses to drug. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002551 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002551">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levacetylmethadol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-03-02T08:31:34Z</oboInOwl:creation_date>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">&lt;new synonym&gt;</oboInOwl:hasRelatedSynonym>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002551</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of levacetylmethadol, a synthetic opioid, similar in structure to methadone, used for the treatment and management of opioid dependence.  Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levomethadyl acetate drug pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002552 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002552">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levacetylmethadol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002551"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-03-02T08:33:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002552</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of levacetylmethadol. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levomethadyl acetate pharmacokinetics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002553 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002553">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levacetylmethadol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002551"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-03-02T08:34:15Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002553</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00677</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of levacetylmethadol-target interaction and of the biochemical or physiological responses to drug. The drug acts as a mu-receptor agonist. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levomethadyl acetate pharmacodynamics pathway</oboInOwl:hasRelatedSynonym>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002554 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002554">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levorphanol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-03-02T08:45:44Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002554</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of levorphanol, an opioid used for the treatment of moderate to severe pain. Primarily an agonist of the mu opioid receptor, levorphanol acts as an agonist or antagonist for several other receptors. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002555 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002555">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levorphanol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002554"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-03-02T08:46:34Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002555</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of levorphanol. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002556 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002556">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">levorphanol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002554"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-03-02T08:46:58Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002556</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00673</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of levorphanol-target interaction and of the biochemical or physiological responses to drug. The drug acts primarily as a mu-receptor agonist, but it can be an agonist or antagonist for several other receptors. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002558 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002558">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">heroin drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002443"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-03-02T09:09:20Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002558</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of heroin, an opioid painkiller and a narcotic. Chemically is 3,6-diacetyl ester of morphine. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002559 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002559">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">heroin pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002558"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-03-02T09:09:48Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002559</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00623</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of heroin. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002560 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002560">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">heroin pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002558"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-03-02T09:10:31Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002560</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00407</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of heroin-target interaction and of the biochemical or physiological responses to drug. Heroin is an opioid painkiller and a narcotic. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VPetri</oboInOwl:created_by>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002570 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002570">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">diphenoxylate drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0000921"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-03-28T09:11:54Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002570</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics of diphenoxylate, a drug of the phenulpiperidine sries used for the treatment of diarrhea. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002571 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002571">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">diphenoxylate pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002570"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-03-28T09:13:04Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002571</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of diphenoxylate. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002572 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002572">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">diphenoxylate pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002570"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-03-28T09:13:43Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002572</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00675</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of diphenoxylate-target interaction and of the biochemical or physiological responses to drug. Diphenoxylate is used for the treatment of diarrhea. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002585 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002585">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">carvedilol drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0001738"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-06T15:41:55Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002585</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of carvedilol - a non-selective adrenergic beta receptor blocker, used in the treatment of mild to severe congestive heart failure. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002586 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002586">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">carvedilol pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002585"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-06T15:42:27Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002586</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of carvedilol. The drug is a non-selective adrenergic beta receptor blocker. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002587 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002587">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">carvedilol pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002585"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-06T15:43:08Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002587</oboInOwl:id>
        <oboInOwl:hasRelatedSynonym rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SMP:00367</oboInOwl:hasRelatedSynonym>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of carvedilol-target interaction and of the biochemical or physiological responses to drug. The drug is non-selective blocker of adrenergic receptor beta belonging to the third generation of blockers. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002593 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002593">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dabigatran drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002146"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-23T13:42:24Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002593</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of dabigatran, a direct thrombin inhibitor. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002594 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002594">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dabigatran pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002593"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-23T13:44:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002594</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of dabigatran, a direct thrombin inhibitor. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002595 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002595">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">dabigatran pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002593"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-23T13:45:00Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002595</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of dabigatran-target interaction and of the biochemical or physiological responses to drug. The drug is a direct thrombin inhibitor. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002596 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002596">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">direct factors Xa inhibitor drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002151"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-23T13:48:18Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002596</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of drugs that reduce or prevent the formation of blood clots by directly inhibiting activated factor X (Xa). Factor X is a serine protease and essential component of coagulation cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002597 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002597">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">apixaban drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002596"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-23T13:53:21Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002597</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of apixaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002598 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002598">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">edoxaban drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002596"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-23T13:54:21Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002598</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of edoxaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002599 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002599">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">rivaroxaban drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002596"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-23T13:54:49Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002599</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of rivaroxaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002600 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002600">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">apixaban pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002597"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-23T13:55:12Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002600</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of apixaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002601 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002601">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">apixaban pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002597"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-23T13:55:37Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002601</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of apixaban-target interaction and of the biochemical or physiological responses to drug. The drug is a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002602 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002602">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">edoxaban pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002598"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-23T13:56:05Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002602</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of edoxaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002603 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002603">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">edoxaban pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002598"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-23T13:56:29Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002603</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of edoxaban-target interaction and of the biochemical or physiological responses to drug. The drug is a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002604 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002604">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">rivaroxaban pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002599"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-23T13:57:09Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002604</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of rivaroxaban, a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002605 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002605">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">rivaroxaban pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002599"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-06-23T13:57:36Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002605</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of rivaroxaban-target interaction and of the biochemical or physiological responses to drug. The drug is a direct inhibitor of activated factor X (Xa) of the coagulation cascade. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002627 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002627">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bortezomib drug pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002367"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-09-29T13:30:17Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002627</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pharmacokinetics and pharmacodynamics pathway of bortezomib, a proteasome inhibitor used in the treatment of several cancer types. Genetic variations can result in changes in drug availability and can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002628 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002628">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bortezomib pharmacokinetics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002627"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-09-29T13:32:31Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002628</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of processing - absorption, distribution, metabolism or elimination - of bortezomib. Genetic variations can result in changes in the availability of the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
    


    <!-- http://purl.obolibrary.org/obo/PW_0002629 -->

    <owl:Class rdf:about="http://purl.obolibrary.org/obo/PW_0002629">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">bortezomib pharmacodynamics pathway</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/PW_0002627"/>
        <oboInOwl:creation_date rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016-09-29T13:33:02Z</oboInOwl:creation_date>
        <oboInOwl:id rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002629</oboInOwl:id>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathway of bortezomib-target interaction and of the biochemical or physiological responses to drug. Bortezomib  is used in the treatment of several cancer types. Genetic variations can cause differences in the response of the organism to the drug.</obo:IAO_0000115>
        <oboInOwl:hasOBONamespace rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pathway</oboInOwl:hasOBONamespace>
        <oboInOwl:created_by rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vpetri</oboInOwl:created_by>
        <obo:IAO_0000412 rdf:resource="http://purl.obolibrary.org/obo/pw.owl"/>
    </owl:Class>
</rdf:RDF>



<!-- Generated by the OWL API (version 1.3.5.1016) http://owlapi.sourceforge.net -->

